<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3167019/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy , </title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167019/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Clinical cancer research : an official journal of the American Association for Cancer Research"><meta name="citation_title" content="Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy , "><meta name="citation_authors" content="Xiang-Lin Tan, Ann M. Moyer, Brooke L. Fridley, Daniel J. Schaid, Nifang Niu, Anthony J. Batzler, Gregory D. Jenkins, Ryan P. Abo, Liang Li, Julie M. Cunningham, Zhifu Sun, Ping Yang, Liewei Wang"><meta name="citation_date" content="1 September 2011"><meta name="citation_issue" content="17"><meta name="citation_volume" content="17"><meta name="citation_firstpage" content="5801"><meta name="citation_doi" content="10.1158/1078-0432.CCR-11-1133"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3167019/?report=abstract"><meta name="citation_pmid" content="21775533"><meta name="DC.Title" content="Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy , "><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Xiang-Lin Tan"><meta name="DC.Contributor" content="Ann M. Moyer"><meta name="DC.Contributor" content="Brooke L. Fridley"><meta name="DC.Contributor" content="Daniel J. Schaid"><meta name="DC.Contributor" content="Nifang Niu"><meta name="DC.Contributor" content="Anthony J. Batzler"><meta name="DC.Contributor" content="Gregory D. Jenkins"><meta name="DC.Contributor" content="Ryan P. Abo"><meta name="DC.Contributor" content="Liang Li"><meta name="DC.Contributor" content="Julie M. Cunningham"><meta name="DC.Contributor" content="Zhifu Sun"><meta name="DC.Contributor" content="Ping Yang"><meta name="DC.Contributor" content="Liewei Wang"><meta name="DC.Date" content="2011 Sep 1"><meta name="DC.Identifier" content="10.1158/1078-0432.CCR-11-1133"><meta name="DC.Language" content="en"><meta property="og:title" content="Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy , "><meta property="og:type" content="article"><meta property="og:description" content="Inherited variability in the prognosis of lung cancer patients treated with platinum-based chemotherapy has been widely investigated. However, the overall contribution of genetic variation to platinum response is not well established. To identify novel ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167019/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3167019/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3167019/pdf/nihms313367.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8AEA9ADD52C03100000000030301F7.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3167019%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3167019</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Clin Cancer Res</a></span>. Author manuscript; available in PMC 2012 Sep 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=21775533" target="pmc_ext" ref="reftype=publisher&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access"><span class="cit">Clin Cancer Res. 2011 Sep 1; 17(17): 5801–5811. </span></a></div><span class="fm-vol-iss-date">Published online 2011 Jul 20. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1158%2F1078-0432.CCR-11-1133" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1158/1078-0432.CCR-11-1133</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3167019</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS313367</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/21775533">21775533</a></div></div></div></div><h1 class="content-title">Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy <sup><a href="#FN1" rid="FN1" class=" fn">†</a></sup><sup>, </sup><sup><a href="#FN2" rid="FN2" class=" fn">‡</a></sup></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Tan%20XL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322410380016" co-class="co-affbox">Xiang-Lin Tan</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Moyer%20AM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322407656432" co-class="co-affbox">Ann M. Moyer</a>,<sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Fridley%20BL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322413513088" co-class="co-affbox">Brooke L. Fridley</a>,<sup>3</sup> <a href="/pubmed/?term=Schaid%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322396613696" co-class="co-affbox">Daniel J. Schaid</a>,<sup>3</sup> <a href="/pubmed/?term=Niu%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322408511536" co-class="co-affbox">Nifang Niu</a>,<sup>1</sup> <a href="/pubmed/?term=Batzler%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322410789792" co-class="co-affbox">Anthony J. Batzler</a>,<sup>3</sup> <a href="/pubmed/?term=Jenkins%20GD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322413896752" co-class="co-affbox">Gregory D. Jenkins</a>,<sup>3</sup> <a href="/pubmed/?term=Abo%20RP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322409410096" co-class="co-affbox">Ryan P. Abo</a>,<sup>1</sup> <a href="/pubmed/?term=Li%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322410857488" co-class="co-affbox">Liang Li</a>,<sup>1</sup> <a href="/pubmed/?term=Cunningham%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322447325472" co-class="co-affbox">Julie M. Cunningham</a>,<sup>4</sup> <a href="/pubmed/?term=Sun%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322447323248" co-class="co-affbox">Zhifu Sun</a>,<sup>2</sup> <a href="/pubmed/?term=Yang%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322397039232" co-class="co-affbox">Ping Yang</a>,<sup>2</sup> and  <a href="/pubmed/?term=Wang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533" class="affpopup" co-rid="_co_idm140322407045296" co-class="co-affbox">Liewei Wang</a><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140322410380016"><h3 class="no_margin">Xiang-Lin Tan</h3><p><sup>1</sup>Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><p><sup>2</sup>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Tan%20XL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Xiang-Lin Tan</a></div></div><div id="_co_idm140322407656432"><h3 class="no_margin">Ann M. Moyer</h3><p><sup>1</sup>Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><p><sup>4</sup>Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Moyer%20AM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Ann M. Moyer</a></div></div><div id="_co_idm140322413513088"><h3 class="no_margin">Brooke L. Fridley</h3><p><sup>3</sup>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Fridley%20BL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Brooke L. Fridley</a></div></div><div id="_co_idm140322396613696"><h3 class="no_margin">Daniel J. Schaid</h3><p><sup>3</sup>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Schaid%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Daniel J. Schaid</a></div></div><div id="_co_idm140322408511536"><h3 class="no_margin">Nifang Niu</h3><p><sup>1</sup>Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Niu%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Nifang Niu</a></div></div><div id="_co_idm140322410789792"><h3 class="no_margin">Anthony J. Batzler</h3><p><sup>3</sup>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Batzler%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Anthony J. Batzler</a></div></div><div id="_co_idm140322413896752"><h3 class="no_margin">Gregory D. Jenkins</h3><p><sup>3</sup>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Jenkins%20GD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Gregory D. Jenkins</a></div></div><div id="_co_idm140322409410096"><h3 class="no_margin">Ryan P. Abo</h3><p><sup>1</sup>Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Abo%20RP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Ryan P. Abo</a></div></div><div id="_co_idm140322410857488"><h3 class="no_margin">Liang Li</h3><p><sup>1</sup>Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Li%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Liang Li</a></div></div><div id="_co_idm140322447325472"><h3 class="no_margin">Julie M. Cunningham</h3><p><sup>4</sup>Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Cunningham%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Julie M. Cunningham</a></div></div><div id="_co_idm140322447323248"><h3 class="no_margin">Zhifu Sun</h3><p><sup>2</sup>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Sun%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Zhifu Sun</a></div></div><div id="_co_idm140322397039232"><h3 class="no_margin">Ping Yang</h3><p><sup>2</sup>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Yang%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Ping Yang</a></div></div><div id="_co_idm140322407045296"><h3 class="no_margin">Liewei Wang</h3><p><sup>1</sup>Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</p><div>Find articles by <a href="/pubmed/?term=Wang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21775533">Liewei Wang</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140322483723408_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140322483723408_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140322483723408_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, 55905, United States of America</div><div id="cor1"><sup>*</sup>To whom correspondence and requests for reprints should be addressed: Liewei Wang M.D., Ph.D., Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN, U.S.A. 55905 <a href="mailto:dev@null" data-email="ude.oyam@ieweil.gnaw" class="oemail">ude.oyam@ieweil.gnaw</a> or <a href="mailto:dev@null" data-email="ude.oyam@nilgnaix.nat" class="oemail">ude.oyam@nilgnaix.nat</a> ; Telephone: 507-284-5264; Fax: 507-284-4455</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140322483723408_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=21775533" target="pmc_ext" ref="reftype=publisher&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Clin Cancer Res</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3167019/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC3167019/bin/NIHMS313367-supplement-1.pdf" data-ga-action="click_feat_suppl">NIHMS313367-supplement-1.pdf</a><span style="color:gray"> (158K)</span></div><div class="small guid">GUID:&nbsp;473F5F10-1153-461F-BE8B-0A7C998A364F</div></div></dd></dl></div><div id="idm140322411152976" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140322411152976title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Purpose</h3><p id="P1" class="p p-first-last">Inherited variability in the prognosis of lung cancer patients treated with platinum-based chemotherapy has been widely investigated. However, the overall contribution of genetic variation to platinum response is not well established. To identify novel candidate SNPs/genes, we performed a genome-wide association study (GWAS) for cisplatin cytotoxicity using lymphoblastoid cell lines (LCLs), followed by an association study of selected SNPs from the GWAS with overall survival (OS) in lung cancer patients.</p></div><div id="S2" class="sec"><h3 id="S2title">Experimental Design</h3><p id="P2" class="p p-first-last">GWAS for cisplatin were performed with 283 ethnically diverse LCLs. 168 top SNPs were genotyped in 222 small cell and 961 non-small cell lung cancer (SCLC, NSCLC) patients treated with platinum-based therapy. Association of the SNPs with OS was determined using the Cox regression model. Selected candidate genes were functionally validated by siRNA knockdown in human lung cancer cells.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">Among 157 successfully genotyped SNPs, 9 and 10 SNPs were top SNPs associated with OS for patients with NSCLC and SCLC, respectively, although they were not significant after adjusting for multiple testing. Fifteen genes, including 7 located within 200 kb up or downstream of the four top SNPs and 8 genes for which expression was correlated with three SNPs in LCLs were selected for siRNA screening. Knockdown of <em>DAPK3</em> and <em>METTL6</em>, for which expression levels were correlated with the rs11169748 and rs2440915 SNPs, significantly decreased cisplatin sensitivity in lung cancer cells.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusions</h3><p id="P4" class="p p-first-last">This series of clinical and complementary laboratory-based functional studies identified several candidate genes/SNPs that might help predict treatment outcomes for platinum-based therapy of lung cancer.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Lung cancer, cisplatin, pharmacogenomics, lymphoblastoid cell lines, GWAS</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">Introduction</h2><p id="P5" class="p p-first">Platinum compounds are the major chemotherapeutic agents used to treat both small cell and non-small cell lung cancer (SCLC and NSCLC), with platinum compounds as the base for combination chemotherapy. Meta-analyses from randomized trials of cisplatin-based chemotherapy versus best supportive care have shown that cisplatin-based chemotherapy was associated with a modest improvement in overall survival (OS) (<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523699">1</a>). Unfortunately, although these agents have shown success in treating lung cancer, the use of platinum-based chemotherapy is limited by the development of chemoresistance and toxicity. In addition, response rates vary greatly among individuals for any given cisplatin-based chemotherapy regimen. Factors such as disease stage, tumor histology, sex, tobacco exposure and patient age may influence platinum-based chemotherapy outcomes. Although tumor DNA is important for drug response, previous studies have shown clearly that germline genetic variations also play an important role in determining treatment outcome (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523693">2</a>–<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523680">4</a>). Therefore, identification and characterization of the role of genetic variation in differential response to platinum may help optimize individual treatment plans and improve platinum treatment outcomes.</p><p id="P6">Chemoresistance and toxicity associated with platinum-based therapy are complex phenotypes that may involve many processes (<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523673">5</a>). These processes include alterations in drug influx or efflux, detoxification through glutathione conjugation, DNA repair capacity and other cellular pathways required for proper response to DNA damage (<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_487657235">6</a>). The development of chemoresistance to platinum agents can be due to germline genetic variation or acquired mutation through their effects on mRNA and protein levels in key pharmacokinetic or pharmacodynamic pathways. Candidate gene and/or candidate pathway approaches indicated that single nucleotide polymorphisms (SNPs) in genes responsible for drug influx and efflux (<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523697">7</a>), metabolism and detoxification (<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523671">8</a>–<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523675">10</a>), and DNA damage repair pathways (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523679">2</a>–<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523686">4</a>, <a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523658">11</a>–<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523692">17</a>), were associated with treatment outcome of lung cancer patients. However, the overall contribution of these genetic biomarkers in the prediction of response to platinum-based therapy is still not well established, suggesting that additional genes might be involved.</p><p id="P7" class="p p-last">Therefore, in the current study, we took a genome-wide approach using 283 lymphoblastoid cell lines (LCLs) to identify SNPs/genes that might contribute to variation in cisplatin cytotoxicity as represented by IC50 values. This step was followed by genotyping top candidate SNPs from the LCL GWAS studies using 1183 DNA samples from lung cancer patients treated with platinum-based therapy to identify SNPs that might be associated with OS. Finally, functional studies of candidate genes identified during the association studies were performed using siRNA knockdown in human lung cancer cells.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Materials and Methods</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Cell lines</h3><p id="P8" class="p p-first-last">This study was reviewed and approved by the Mayo Clinic Institutional Review Board. Human Variation Panel LCLs from sample sets HD100AA, HD100CAU, HD100CHI, corresponding to 100 African-American (AA), 100 Caucasian-American (CA), and 100 Han Chinese-American (HCA) unrelated subjects, were obtained from the Coriell Cell Repository (Camden, NJ). The National Institute of General Medical Sciences had obtained and anonymized these cell lines before deposit, and all subjects had provided written informed consent for the use of their samples for research purposes. Human NSCLC cell lines H1437, H1299 and the SCLC cell line H196 were obtained from the American Type Culture Collection (Manassas, VA). LCLs were cultured in RPMI 1640 medium (Mediatech, Manassas, VA) supplemented with 15% FBS (Mediatech). H1437, H1299 and H196 cell lines were cultured in RPMI 1640 medium containing 10% FBS.</p></div><div id="S8" class="sec"><h3 id="S8title">Patient samples</h3><p id="P9" class="p p-first-last">The study group included 1183 Caucasian patients with pathologically confirmed primary lung cancer, 222 SCLC and 961 NSCLC, who were treated with platinum-based chemotherapy at the Mayo Clinic (Rochester, MN) between 1997 and 2008. Details with regard to clinical characteristics of patients, patient enrollment, diagnosis, and data collection procedures were described previously (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523657">18</a>–<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523703">20</a>). Briefly, each patient was identified through the Mayo Clinic pathologic database. After written informed consent had been obtained, a blood sample was collected. The characteristics of patients, including demographics, lung cancer pathology, anatomic site, and types and timing of treatment and chemotherapeutic agents, were abstracted from patient medical records by a trained nurse. Vital status and cause of death were determined by reviewing the Mayo Clinic registration database and medical records, correspondence from patients' next-of-kin, death certificates, obituary documents, the Mayo Clinic Tumor Registry, and the Social Security Death Index website. Clinical staging and recurrence or progression information was determined by results from available chest radiography, computerized tomography, bone scans, positron emission tomography scans, and magnetic response imaging. All patients were actively followed up during the initial six months after diagnosis, with subsequent annual follow-up by mailed questionnaires and annual verification of the patients’ vital status.</p></div><div id="S9" class="sec"><h3 id="S9title">Cisplatin cytotoxicity assay</h3><p id="P10" class="p p-first-last">Cisplatin was obtained from Sigma-Aldrich (St. Louis, MO) and was dissolved in dimethyl sulfoxide (DMSO) immediately before use. Cells (4 ×10<sup>4</sup> cells/well) were plated into 96-well plates, and incubated with cisplatin for 72 h in eight concentrations ranging from 0.1 to 80 µmol/L. DMSO alone was used as a control. Cisplatin cytotoxicity was evaluated by determining the concentration of cisplatin required to inhibit growth and/or survival by 50% (IC50) using the CellTiter 96@ Aqueous Non-Radioactive Cell Proliferation Assay (Promega, Madison, WI). Experiments were performed successfully for 283 LCLs (91 AA, 96 CA, and 96 HCA).</p></div><div id="S10" class="sec"><h3 id="S10title">Genome-wide SNP and expression arrays for LCLs</h3><p id="P11" class="p p-first-last">The genotyping and expression array data for all LCLs were described previously (<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523656">21</a>–<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523663">23</a>) and are publically available from NCBI Gene Expression Omnibus (<a href="http://www.ncbi.nlm.nih.gov/geo" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/geo</a>) under SuperSeries accession No. <a id="__tag_231523705" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE24277" ref="/geo/query/acc.cgi?acc=GSE24277"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE24277","term_id":"24277"}}</span>GSE24277</a> and accession No. <a id="__tag_231523704" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE23120" ref="/geo/query/acc.cgi?acc=GSE23120"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE23120","term_id":"23120"}}</span>GSE23120</a>. Briefly, Illumina HumanHap 550K and 510S BeadChips were used for genotyping of DNA samples from all of the LCLs in the Genotype Shared Resource at Mayo Clinic. Publicly available Affymetrix SNP Array 6.0 Chip SNP data were also obtained for the same cell lines. SNPs that deviated from Hardy-Weinberg Equilibrium (HWE) (<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523665">24</a>) based on minimum <em>P</em> value from an exact test for HWE (<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523669">25</a>) and the stratified test for HWE (<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523683">26</a>) (<em>P</em> &lt; 0.001); SNPs with call rates &lt; 95%; or SNPs with minor allele frequency (MAF) &lt; 5% were removed from the analysis (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523684">27</a>, <a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523685">28</a>). As a result, 1,348,798 SNPs that passed these quality control measures were included in the GWA analyses of SNP <em>vs</em>. IC50 and SNP <em>vs</em>. expression.</p></div><div id="S11" class="sec"><h3 id="S11title">SNP selection and genotyping in lung cancer patients</h3><p id="P12" class="p p-first">SNP selection was based on <em>P</em> values obtained during the analysis of genome-wide SNP <em>vs.</em> IC50, and SNP <em>vs.</em> expression, as well as expression <em>vs.</em> IC50 using LCL data. We selected all SNPs with <em>P</em> &lt; 10<sup>−5</sup> from the SNP <em>vs.</em> IC50 analysis. Additionally, we defined a SNP peak as a locus that contained at least two SNPs associated with cisplatin IC50 with <em>P</em> &lt;10<sup>−4</sup>. SNPs within the SNP peaks were used to perform an association study with 54,613 expression probesets to identify SNPs that were associated with gene expression (<em>P</em> &lt; 10<sup>−4</sup>). Finally an association study was performed with gene expression and cisplatin IC50 to identify SNPs that might be associated with cisplatin IC50 through an influence on gene expression. Therefore, we also selected SNPs with SNP <em>vs.</em> expression: <em>P</em> value &lt; 10<sup>−4</sup> and expression <em>vs.</em> IC50: <em>P</em> value &lt; 10<sup>−4</sup> to genotype the patient samples (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a>).</p><p id="P13" class="p p-last">A total of 168 top hit SNPs were selected and genotyped in 1183 lung cancer patients who received platinum-based chemotherapy. Genotyping was performed in the Mayo Clinic Genomics Shared Resource using a custom-designed Illumina GoldenGate panel. Quality control tests of the genotyping results were performed by assessing concordance among three control DNA samples that were present in duplicate, SNP call rates, sample call rates, MAF of SNPs or departure of SNP genotypes from HWE. SNPs were excluded if they failed genotyping, or displayed ambiguous clustering monomorphic genotyping, MAFs of &lt;0.01, or significant departures from HWE (<em>P</em> &lt; 0.001). SNPs having call rates &gt; 95% but which passed all other quality control tests were included in the analysis. Of the SNPs with genotyping data, 157 SNPs passed the quality control tests and were included in the analyses.</p></div><div id="S12" class="sec"><h3 id="S12title">Functional validation by siRNA knockdown</h3><p id="P14" class="p p-first-last">Human NSCLC cell lines, H1437, H1299 and the SCLC cell line, H196, were used in siRNA screening studies. siRNAs for the candidate genes and non-targeting negative control siRNA pool were purchased from Dharmacon (Hiden, Germany). Specifically, approximately 3,000–4,000 cells were seeded into 96-well plates, mixed with an siRNA-mixture consisting of 25 nmol/L of specific or negative control siRNAs and the Lipofectamine™ RNAiMAX reagent (Invitrogen, Carlsbad, CA). Twenty-four hours after transfection, the cells were treated with vehicle or increasing concentrations of cisplatin for an additional 72 h, followed by MTS assay using the CellTiter 96@ Aqueous Non-Radioactive Cell Proliferation Assay.</p></div><div id="S13" class="sec"><h3 id="S13title">Knockdown efficiency determination by real-time RT-PCR and Western blot analysis</h3><p id="P15" class="p p-first-last">Total RNA was isolated from cultured cells transfected with controls or specific siRNAs with the Mini RNA isolation kit (ZYMO Research, Orange, CA), followed by qRT-PCR performed with the 1-step, Brilliant SYBR Green qRT-PCR master mix kit (Stratagene, La Jolla, CA). Specifically, primers purchased from QIAGEN were used to perform qRT-PCR using the ABI StepOne™ Real-Time PCR System (Applied Biosystems). Western Blots were performed for DAPK3, METTL6 and RUFY1 using goat polyclonal antibodies purchased from Santa Cruz biotechnology, Inc. All experiments were performed in triplicate with β-actin as an internal control.</p></div><div id="S14" class="sec sec-last"><h3 id="S14title">Statistical analysis</h3><p id="P16" class="p p-first">A detailed description for GWAS of LCLs has been described elsewhere (<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523694">21</a>–<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523698">23</a>). Briefly, the cisplatin cytotoxicity IC50 phenotype was calculated for each cell line based on a logistic dose-response model using the R package ‘drc’ (<a href="http://cran.r-project.org/doc/packages/drc.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://cran.r-project.org/doc/packages/drc.pdf</a>). Logarithm transformed IC50 values were then compared between genders, batches of samples based on time since purchase, and between the CA race and all other samples using independent samples t-tests. An overall comparison of transformed IC50 values among ethnic groups was performed using an F-test based on ANOVA. Because we used LCLs from multiple races/ethnic groups, population stratification was adjusted using the method developed by Price <em>et al</em>. (<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523674">29</a>), which uses an eigen analysis for detecting and adjusting. SNPs. The log transformed IC50 values and GCRMA normalized expression data were adjusted for race using the five eigenvectors. The GWA analysis of the association of SNP <em>vs</em>. IC50 or SNP <em>vs</em>. expression was performed with Pearson correlations using adjusted SNP, IC50 and expression values for each individual. For the siRNA knockdown experiments, group mean values of IC50 were compared using Student's <em>t</em> test.</p><p id="P17" class="p p-last">The overall survival time was used as the primary endpoint, defined as the time from lung cancer diagnosis to either death or the last known date alive. Patients known to be alive were censored at the time of last contact. All the patients included in the analysis were Caucasians. To test for the effect of SNP on OS, we used the Cox regression model that included the effects of a SNP genotype dosage (count of minor alleles). A total of 157 SNPs were included in this analysis, and the association was performed for NSCLC and SCLC separately because of significant differences between the two diseases. To correct for multiple testing of the 157 SNPs assayed in the initial experiment, the Bonferroni corrected <em>P</em> value threshold of 0.0003 was used to determine statistically significant associations. To determine whether associations with SNPs should be adjusted for the clinical covariates of age at diagnosis, gender, smoking status, disease stage, and treatment, backward selection was done. The disease stage was included in the final multivariate Cox-regression model since it was significantly associated with OS of the lung cancer patients. The disease stage was divided into five categories: small cell lung cancer with limited versus extensive stages; NSCLC with stages I and II, versus III, versus IV. We used 0.05 as a cutoff for <em>P</em> values (not adjusted for multiple testing) to select SNPs/genes for further functional validation.</p></div></div><div id="S15" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S15title">Results</h2><div id="S16" class="sec sec-first"><h3 id="S16title">Correlation analysis of genome-wide SNP vs cisplatin IC50 in LCLs</h3><p id="P18" class="p p-first">Cytotoxicity assays were performed for cisplatin to determine the range of variation in drug response, and IC50 was used as a phenotype to indicate the drug sensitivity for each cell line. The unadjusted average IC50 value for cisplatin in these 283 cell lines was 1.79 ± 1.64 (mean ± SD) µmol/L. Gender had no significant effect on IC50 values (<em>P</em> = 0.15). Caucasian Americans (CAs) were more sensitive to cisplatin compared to the other two races (AAs and HCAs) (<em>P</em> = 0.0001). Time since the Coriell Institute acquired the cell lines had no significant effect on cisplatin cytotoxicity (<em>P</em> = 0.64).</p><p id="P19" class="p p-last">A total of 1,348,789 SNPS were used in the genome-wide SNP analysis for 283 cell lines. <a href="/pmc/articles/PMC3167019/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1A</span></a> depicts the association results graphically. 364 SNPs were associated with cisplatin IC50 with <em>P</em> values &lt; 10<sup>−4</sup>, and 50 SNPs had <em>P</em> values &lt; 10<sup>−5</sup>. None of the top 50 SNPs were within the coding region of a gene. Twenty-three, 16 and 11 SNPs were in introns, 5’-upstream or 3’-downstream flanking regions of genes, respectively. The top three SNPs from the GWAS were rs6633130 (<em>P</em> = 1.66 × 10<sup>−7</sup>), rs6946197 (<em>P</em> = 1.99 × 10<sup>−7</sup>) and rs12304656 (<em>P</em> = 3.64 × 10<sup>−7</sup>) at loci containing the PPEF1 (intron), LOC100128030 (3’downstream) and STYK1 (intron) genes, respectively.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3167019/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140322409516480" class="figure"><a href="/pmc/articles/PMC3167019/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3167019_nihms313367f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms313367f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3167019/bin/nihms313367f1.jpg"></a></div><div id="largeobj_idm140322409516480" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3167019/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3167019/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Genome-wide SNP association with cisplatin IC50 values (A) and the strategies used to select candidate genes for siRNA validation (B)</strong><p id="P47">Genome-wide SNP association analysis was performed with cisplatin IC50 as the drug-response phenotype (n = 283). The y-axis represents the -log10(<em>P</em> value) for association of SNPs and IC50 values. SNPs are plotted on the x-axis on the basis of their chromosomal locations. The cut-off <em>P</em> value of 10<sup>−5</sup> is highlighted with a black line. Detailed strategies for the selection of candidate genes have been described in the text. OS, overall survival; LCLs, lymphoblastoid cell lines.</p></div></div></div></div><div id="S17" class="sec"><h3 id="S17title">Survival analysis for the selected SNPs and lung cancer patient samples</h3><p id="P20" class="p p-first">A total of 168 SNPs were selected and genotyped to determine whether any of those SNPs might be associated with patient OS. <a href="/pmc/articles/PMC3167019/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> lists basic demographic and clinic data with regard to the patients studied. Of these patients, 656 (55.5%) were male and 527 (44.5%) were female, with a median age of 63.0 years. Most patients had a history of smoking, with 47.3% (n = 560) being former smokers and 36.5% (n = 431) current smokers. 550 (46.5%) tumors were classified as adenocarcinoma, 194 (16.4%) as squamous cell carcinoma and 222 (18.8%) as small cell carcinoma. 881 (74.5%) patients received platinum drugs in combination of surgery and/or radiation, and 302 (25.5%) patients received only platinum drugs.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="P50">Description of 1183 patients who were diagnosed with primary lung cancer and received platinum-based chemotherapy.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140322403978720" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left">Characteristics of diagnosis and treatment</th><th rowspan="1" colspan="1" align="left">Values and percentages</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">Age at diagnosis</td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Mean (SD)</td><td rowspan="1" colspan="1" align="left">62.3 (10.34)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Median (range)</td><td rowspan="1" colspan="1" align="left">63.0 (27.0–88.0)</td></tr><tr><td rowspan="1" colspan="1" align="left">Gender, <em>n</em> (%)</td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Female</td><td rowspan="1" colspan="1" align="left">527 (44.5%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Male</td><td rowspan="1" colspan="1" align="left">656 (55.5%)</td></tr><tr><td rowspan="1" colspan="1" align="left">Cigarette smoking status</td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Never</td><td rowspan="1" colspan="1" align="left">192 (16.2%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Former smokers</td><td rowspan="1" colspan="1" align="left">560 (47.3%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Current smokers</td><td rowspan="1" colspan="1" align="left">431 (36.5%)</td></tr><tr><td rowspan="1" colspan="1" align="left">Lung cancer stage <sup>a</sup></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Unknown</td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;SCLC: LIMITED</td><td rowspan="1" colspan="1" align="left">129 (10.9%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EXTENSIVE</td><td rowspan="1" colspan="1" align="left">93 (7.9%)</td></tr><tr><td rowspan="1" colspan="1" align="left">NSCLC: I</td><td rowspan="1" colspan="1" align="left">123 (10.4%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;II</td><td rowspan="1" colspan="1" align="left">82 (6.9%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;III</td><td rowspan="1" colspan="1" align="left">403 (34.1%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;&nbsp;&nbsp;IV</td><td rowspan="1" colspan="1" align="left">353 (29.8%)</td></tr><tr><td rowspan="1" colspan="1" align="left">Histologic cell type</td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Adenocarcinoma</td><td rowspan="1" colspan="1" align="left">550 (46.5%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Squamous cell carcinoma</td><td rowspan="1" colspan="1" align="left">194 (16.4%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Small cell carcinoma</td><td rowspan="1" colspan="1" align="left">222 (18.8%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Large cell carcinoma</td><td rowspan="1" colspan="1" align="left">39 (3.3%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Mixed and unspecified NSCLC</td><td rowspan="1" colspan="1" align="left">167 (14.1%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Carcinoid or salivary gland tumors</td><td rowspan="1" colspan="1" align="left">11 (0.9%)</td></tr><tr><td rowspan="1" colspan="1" align="left">Tumor differentiation grade</td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Nongradable or unknown</td><td rowspan="1" colspan="1" align="left">80 (6.8%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Well differentiated</td><td rowspan="1" colspan="1" align="left">91 (7.7%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Moderately differentiated</td><td rowspan="1" colspan="1" align="left">392 (33.1%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Poor/undifferentiated</td><td rowspan="1" colspan="1" align="left">620 (52.4)</td></tr><tr><td rowspan="1" colspan="1" align="left">Treatment modality</td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Only platinum drugs</td><td rowspan="1" colspan="1" align="left">302 (25.5%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Surgery and platinum drugs</td><td rowspan="1" colspan="1" align="left">192 (16.2%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Radiation and platinum drugs</td><td rowspan="1" colspan="1" align="left">455 (38.5%)</td></tr><tr><td rowspan="1" colspan="1" align="left">&nbsp;&nbsp;Surgery, radiation, and platinum drugs</td><td rowspan="1" colspan="1" align="left">234 (19.8%)</td></tr></tbody></table></div><div id="largeobj_idm140322403978720" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3167019/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>a</sup>Stage for NSCLC is described on the basis of the tumor-node-metastasis classification. The small cell lung cancer stage is described as suggested by the American Cancer Society as either “EXTENSIVE” or “LIMITED.”</div></div></div><p id="P21" class="p p-last">Only disease stage was included in the analysis as a confounder among all the others tested including age at diagnosis, gender and smoking status. Nine and 10 different SNPs were associated with OS for NSCLC and SCLC patients, respectively (<em>P</em> &lt; 0.05) (<a href="/pmc/articles/PMC3167019/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Fig. 1</a>). However none of the SNPs were statistically significant after correcting for multiple testing. The most significant SNPs for NSCLC and SCLC, rs1287276 (located within an intron of <em>UGT3A2</em> on chromosome 5) and rs12669805 (located 3’-downstream of the LOC100128030 pseudogene on chromosome 7) were associated with OS in NSCLC (<em>P</em> = 0.0004) and SCLC (<em>P</em> = 0.0021), respectively. A hazard ratio &gt; 1 indicated that patients carrying the minor allele had worse survival. These SNPs would also be expected to be associated with higher IC50 values in LCLs, and the cells carrying these SNPs would be predicted to be more resistant to cisplatin. Therefore, 12 out of the 19 SNPs showed concordant association directions between the two results (<a href="/pmc/articles/PMC3167019/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), when we compared the association direction of SNPs with clinical OS with that of the same SNP with cisplatin IC50 values in LCLs.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="P52">The 19 SNPs with the lowest unadjusted <em>P</em> values that were associated with the overall survival of lung cancer patients treated with platinum compounds.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140322407737488" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="left"></th><th colspan="3" rowspan="1" align="center">LCL GWAS</th><th colspan="3" rowspan="1" align="center">Clinical Study</th></tr><tr><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="left"></th><th colspan="6" rowspan="1" valign="bottom" align="center"><hr></th></tr><tr><th rowspan="1" colspan="1" align="left">SNP</th><th rowspan="1" colspan="1" align="left">Chr.</th><th rowspan="1" colspan="1" align="left">SNP position</th><th rowspan="1" colspan="1" align="left">MAF</th><th rowspan="1" colspan="1" align="left"><em>R</em> value<sup>a</sup></th><th rowspan="1" colspan="1" align="left"><em>P</em> value</th><th rowspan="1" colspan="1" align="left">MAF</th><th rowspan="1" colspan="1" align="left">HR (95% CI) <sup>b</sup></th><th rowspan="1" colspan="1" align="left"><em>P</em> value</th></tr></thead><tbody><tr><td colspan="2" rowspan="1" align="left"><em>Among NSCLC patients</em></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs1287276</td><td rowspan="1" colspan="1" align="left">5</td><td rowspan="1" colspan="1" align="left">36083458</td><td rowspan="1" colspan="1" align="left">0.242</td><td rowspan="1" colspan="1" align="left">−0.247</td><td rowspan="1" colspan="1" align="left">4.72E-05</td><td rowspan="1" colspan="1" align="left">0.095</td><td rowspan="1" colspan="1" align="left">1.36 (1.15–1.61)</td><td rowspan="1" colspan="1" align="left">0.0004</td></tr><tr><td rowspan="1" colspan="1" align="left">rs9405302 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">8228049</td><td rowspan="1" colspan="1" align="left">0.394</td><td rowspan="1" colspan="1" align="left">0.267</td><td rowspan="1" colspan="1" align="left">1.08E-05</td><td rowspan="1" colspan="1" align="left">0.211</td><td rowspan="1" colspan="1" align="left">1.22 (1.08–1.37)</td><td rowspan="1" colspan="1" align="left">0.001</td></tr><tr><td rowspan="1" colspan="1" align="left">rs8064630</td><td rowspan="1" colspan="1" align="left">17</td><td rowspan="1" colspan="1" align="left">3789240</td><td rowspan="1" colspan="1" align="left">0.152</td><td rowspan="1" colspan="1" align="left">0.251</td><td rowspan="1" colspan="1" align="left">3.61E-05</td><td rowspan="1" colspan="1" align="left">0.187</td><td rowspan="1" colspan="1" align="left">0.82 (0.71–0.94)</td><td rowspan="1" colspan="1" align="left">0.004</td></tr><tr><td rowspan="1" colspan="1" align="left">rs5970160 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">23</td><td rowspan="1" colspan="1" align="left">150844654</td><td rowspan="1" colspan="1" align="left">0.17</td><td rowspan="1" colspan="1" align="left">0.259</td><td rowspan="1" colspan="1" align="left">2.25E-05</td><td rowspan="1" colspan="1" align="left">0.126</td><td rowspan="1" colspan="1" align="left">1.17 (1.05–1.31)</td><td rowspan="1" colspan="1" align="left">0.006</td></tr><tr><td rowspan="1" colspan="1" align="left">rs1946518</td><td rowspan="1" colspan="1" align="left">11</td><td rowspan="1" colspan="1" align="left">111540668</td><td rowspan="1" colspan="1" align="left">0.384</td><td rowspan="1" colspan="1" align="left">0.249</td><td rowspan="1" colspan="1" align="left">5.55E-05</td><td rowspan="1" colspan="1" align="left">0.396</td><td rowspan="1" colspan="1" align="left">0.87 (0.78–0.96)</td><td rowspan="1" colspan="1" align="left">0.008</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2440915 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">10</td><td rowspan="1" colspan="1" align="left">61343778</td><td rowspan="1" colspan="1" align="left">0.058</td><td rowspan="1" colspan="1" align="left">0.249</td><td rowspan="1" colspan="1" align="left">4.10E-05</td><td rowspan="1" colspan="1" align="left">0.029</td><td rowspan="1" colspan="1" align="left">1.41 (1.08–1.83)</td><td rowspan="1" colspan="1" align="left">0.012</td></tr><tr><td rowspan="1" colspan="1" align="left">rs5952066 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">23</td><td rowspan="1" colspan="1" align="left">146692840</td><td rowspan="1" colspan="1" align="left">0.178</td><td rowspan="1" colspan="1" align="left">0.242</td><td rowspan="1" colspan="1" align="left">6.92E-05</td><td rowspan="1" colspan="1" align="left">0.2</td><td rowspan="1" colspan="1" align="left">1.14 (1.03–1.26)</td><td rowspan="1" colspan="1" align="left">0.014</td></tr><tr><td rowspan="1" colspan="1" align="left">rs901893 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">5</td><td rowspan="1" colspan="1" align="left">8228049</td><td rowspan="1" colspan="1" align="left">0.353</td><td rowspan="1" colspan="1" align="left">0.239</td><td rowspan="1" colspan="1" align="left">8.53E-05</td><td rowspan="1" colspan="1" align="left">0.337</td><td rowspan="1" colspan="1" align="left">1.14 (1.02–1.27)</td><td rowspan="1" colspan="1" align="left">0.018</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11169748 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">12</td><td rowspan="1" colspan="1" align="left">49865438</td><td rowspan="1" colspan="1" align="left">0.062</td><td rowspan="1" colspan="1" align="left">0.237</td><td rowspan="1" colspan="1" align="left">9.60E-05</td><td rowspan="1" colspan="1" align="left">0.011</td><td rowspan="1" colspan="1" align="left">1.75 (1.03–2.97)</td><td rowspan="1" colspan="1" align="left">0.039</td></tr><tr><td colspan="2" rowspan="1" align="left"><em>Among SCLC patients</em></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">rs12669805 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">7</td><td rowspan="1" colspan="1" align="left">79509055</td><td rowspan="1" colspan="1" align="left">0.188</td><td rowspan="1" colspan="1" align="left">0.253</td><td rowspan="1" colspan="1" align="left">3.32E-05</td><td rowspan="1" colspan="1" align="left">0.024</td><td rowspan="1" colspan="1" align="left">3.42 (1.56–7.48)</td><td rowspan="1" colspan="1" align="left">0.002</td></tr><tr><td rowspan="1" colspan="1" align="left">rs6092092 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">20</td><td rowspan="1" colspan="1" align="left">53291685</td><td rowspan="1" colspan="1" align="left">0.076</td><td rowspan="1" colspan="1" align="left">0.249</td><td rowspan="1" colspan="1" align="left">4.28E-05</td><td rowspan="1" colspan="1" align="left">0.006</td><td rowspan="1" colspan="1" align="left">7.74 (1.85–32.30)</td><td rowspan="1" colspan="1" align="left">0.005</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2833537</td><td rowspan="1" colspan="1" align="left">21</td><td rowspan="1" colspan="1" align="left">32135333</td><td rowspan="1" colspan="1" align="left">0.074</td><td rowspan="1" colspan="1" align="left">0.254</td><td rowspan="1" colspan="1" align="left">3.03E-05</td><td rowspan="1" colspan="1" align="left">0.036</td><td rowspan="1" colspan="1" align="left">0.40 (0.20–0.79)</td><td rowspan="1" colspan="1" align="left">0.008</td></tr><tr><td rowspan="1" colspan="1" align="left">rs7620841 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">3</td><td rowspan="1" colspan="1" align="left">187425014</td><td rowspan="1" colspan="1" align="left">0.06</td><td rowspan="1" colspan="1" align="left">0.242</td><td rowspan="1" colspan="1" align="left">6.77E-05</td><td rowspan="1" colspan="1" align="left">0.052</td><td rowspan="1" colspan="1" align="left">1.80 (1.12–2.89)</td><td rowspan="1" colspan="1" align="left">0.015</td></tr><tr><td rowspan="1" colspan="1" align="left">rs1921626 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">2</td><td rowspan="1" colspan="1" align="left">77025574</td><td rowspan="1" colspan="1" align="left">0.205</td><td rowspan="1" colspan="1" align="left">0.238</td><td rowspan="1" colspan="1" align="left">9.00E-05</td><td rowspan="1" colspan="1" align="left">0.084</td><td rowspan="1" colspan="1" align="left">1.57 (1.09–2.26)</td><td rowspan="1" colspan="1" align="left">0.015</td></tr><tr><td rowspan="1" colspan="1" align="left">rs17043088</td><td rowspan="1" colspan="1" align="left">12</td><td rowspan="1" colspan="1" align="left">76103718</td><td rowspan="1" colspan="1" align="left">0.104</td><td rowspan="1" colspan="1" align="left">−0.238</td><td rowspan="1" colspan="1" align="left">8.88E-05</td><td rowspan="1" colspan="1" align="left">0.026</td><td rowspan="1" colspan="1" align="left">2.21 (1.16–4.22)</td><td rowspan="1" colspan="1" align="left">0.016</td></tr><tr><td rowspan="1" colspan="1" align="left">rs753921 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">4</td><td rowspan="1" colspan="1" align="left">35579894</td><td rowspan="1" colspan="1" align="left">0.231</td><td rowspan="1" colspan="1" align="left">0.239</td><td rowspan="1" colspan="1" align="left">8.69E-05</td><td rowspan="1" colspan="1" align="left">0.274</td><td rowspan="1" colspan="1" align="left">1.31 (1.05–1.64)</td><td rowspan="1" colspan="1" align="left">0.018</td></tr><tr><td rowspan="1" colspan="1" align="left">rs7618373</td><td rowspan="1" colspan="1" align="left">3</td><td rowspan="1" colspan="1" align="left">177819713</td><td rowspan="1" colspan="1" align="left">0.446</td><td rowspan="1" colspan="1" align="left">−0.255</td><td rowspan="1" colspan="1" align="left">3.17E-05</td><td rowspan="1" colspan="1" align="left">0.378</td><td rowspan="1" colspan="1" align="left">1.27 (1.02–1.57)</td><td rowspan="1" colspan="1" align="left">0.03</td></tr><tr><td rowspan="1" colspan="1" align="left">rs5916072</td><td rowspan="1" colspan="1" align="left">23</td><td rowspan="1" colspan="1" align="left">5406196</td><td rowspan="1" colspan="1" align="left">0.343</td><td rowspan="1" colspan="1" align="left">0.247</td><td rowspan="1" colspan="1" align="left">5.04E-05</td><td rowspan="1" colspan="1" align="left">0.442</td><td rowspan="1" colspan="1" align="left">0.84 (0.70–1.00)</td><td rowspan="1" colspan="1" align="left">0.046</td></tr><tr><td rowspan="1" colspan="1" align="left">rs10517364 <sup>c</sup></td><td rowspan="1" colspan="1" align="left">4</td><td rowspan="1" colspan="1" align="left">35562853</td><td rowspan="1" colspan="1" align="left">0.246</td><td rowspan="1" colspan="1" align="left">0.258</td><td rowspan="1" colspan="1" align="left">2.12E-05</td><td rowspan="1" colspan="1" align="left">0.31</td><td rowspan="1" colspan="1" align="left">1.23 (1.00–1.52)</td><td rowspan="1" colspan="1" align="left">0.05</td></tr></tbody></table></div><div id="largeobj_idm140322407737488" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3167019/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN2"><sup>a</sup><em>R</em> values represent correlation coefficients for the associations between SNPs and cisplatin IC50.</div><div id="TFN3"><sup>b</sup>HR, hazard ratios; if HR &gt; 1, patients carrying the minor allele had worse overall survival.</div><div id="TFN4"><sup>c</sup>SNP showed a concordant association with the IC50 and OS phenotype.</div></div></div></div><div id="S18" class="sec sec-last"><h3 id="S18title">Functional characterization of candidate gene</h3><p id="P22" class="p p-first">Although none of the SNPs studied in the patient samples reached statistical significance after multiple testing, to further pursue the possibility that the locus harboring these SNPs might include functional genes, we took advantage of the expression data we had for the cell lines (<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523678">21</a>–<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523677">23</a>) to help interpret SNP function and guide the selection of genes for siRNA screening. The overall selection strategy is depicted graphically in <a href="/pmc/articles/PMC3167019/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>. First, we focused on genes located within 200 kb up or downstream of the 12 SNPs which showed a concordant association with the IC50 phenotype in LCLs and the OS phenotype in patients. 39 genes were found to be located within 200 kb up or downstream of these SNPs, and 7 out of the 39 genes close to 4 SNPs had the expression levels &gt; 50 in LCLs after GCRMA normalization (<a href="/pmc/articles/PMC3167019/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B</span></a>). Next, since SNPs might influence cisplatin response through the regulation of gene expression by either cis- or trans-regulation, we also performed association analysis using the genotyping data for these 12 SNPs and basal expression array data (54,613 expression probesets) available for all of the LCLs. Eight of 12 SNPs were associated with the expression of 212 probesets (154 unique genes) using a cutoff <em>P</em> value &lt;10<sup>−4</sup>, and 4 of 12 SNPs were associated with mRNA expression levels of 54 genes with <em>P</em> value &lt;10<sup>−5</sup> (<a href="/pmc/articles/PMC3167019/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B</span></a>). No cis-regulation was identified. We selected these 54 genes plus 2 genes with multiple probesets associated with the SNPs to check expression levels in LCLs. However, only 8 of these genes had the expression levels &gt; 50 after GCRMA normalization. Finally, 15 genes, including 7 genes located within 200 kb up or downstream of 4 SNPs (rs11169748, rs2440915, rs5952066 and rs7620841) and 8 genes for which expression was correlated with three SNPs (rs11169748, rs2440915 and rs5952066) were selected for siRNA screening (<a href="/pmc/articles/PMC3167019/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B</span></a>).</p><p id="P23" class="p p-last">We performed knockdown experiments for these 15 genes in the NSCLC cell lines H1437 and H1299 and in the SCLC cell line H196. Knockdown of <em>DAPK3</em> and <em>METTL6</em> significantly decreased cisplatin sensitivity in all three lung cancer cell lines, while knockdown of <em>RUFY1</em> did not significantly alter cisplatin cytotoxicity (<a href="/pmc/articles/PMC3167019/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>). The rs11169748 and rs2440915 SNPs that were associated with lung cancer OS were also correlated with cisplatin IC50 values in LCLs. In addition, these two SNPs were also associated with expression of <em>DAPK3</em> and <em>METTL6</em> in LCLs (<a href="/pmc/articles/PMC3167019/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>). However only <em>DAPK3</em> expression level was associated with cisplatin IC50 (<em>P</em> = 0.03) in LCLs, while <em>METTL6</em> was not (<em>P</em> = 0.32). To obtain ungenotyped SNPs, we imputed SNPs that were not on our genotyping platform and that were located within 200 kb up or downstream of these two SNPs (rs11169748 and rs2440915), using MACH 1.0 (<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_246984938">30</a>), with 1000 Genome Project data (<a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523687">31</a>) as the reference panel. We observed no stronger association with cisplatin IC50 for the imputed SNPs, compared to the observed SNPs (<a href="/pmc/articles/PMC3167019/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3E and F</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3167019/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140322410403472" class="figure"><a href="/pmc/articles/PMC3167019/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3167019_nihms313367f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms313367f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3167019/bin/nihms313367f2.jpg"></a></div><div id="largeobj_idm140322410403472" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3167019/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3167019/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Functional characterizations of candidate genes with siRNA knockdown of DAPK3 and METTL6</strong><p id="P48">Knockdown of <em>DAPK3</em> and <em>METTL6</em> in human NSCLC cell lines, H1437 (A), H1299 (B) and the SCLC cell line, H196 (C), showed increased resistance to cisplatin. A control was also included in which knockdown of <em>RUFY1</em> did not significant change the response to cisplatin as determined by MTS assay. Quantitative RT-PCR (D) and western blot (E) were performed to determine the knockdown efficiency for the three genes. RT-PCR results are expressed as % of control. Error bars represent standard error of mean (SEM) values for 3 independent experiments.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3167019/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140322408443296" class="figure"><a href="/pmc/articles/PMC3167019/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3167019_nihms313367f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms313367f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3167019/bin/nihms313367f3.jpg"></a></div><div id="largeobj_idm140322408443296" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3167019/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3167019/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Association between the rs1169748 and rs2440915 SNPs and cisplatin IC50 values and expression of DAPK3 and METTL6 in LCLs, as well as imputation analyses for these two SNPs</strong><p id="P49">Genotypes for each SNP are plotted against cisplatin IC50 values as well as gene expression levels of DAPK3 and METTL6, respectively. (A and C) SNP rs1169748 association with cisplatin IC50 values and DAPK3 expression; (B and D) SNP rs2440915 association with cisplatin IC50 values and METTL6 expression; (E and F) imputation analysis for the rs1169748 and rs2440915 SNPs. Black circles indicate SNPs observed by genotyping, while black triangles indicate imputed SNPs. The y-axis represents −log10(<em>P</em> value) for the association of each SNP with cisplatin IC50, and the x-axis represents the chromosome location of the SNPs. No stronger association with cisplatin IC50 were observed for the imputed SNPs, compared to the genotyped SNPs. AA, African Americans; CA, Caucasian Americans; and HCA, Han-Chinese Americans.</p></div></div></div></div></div><div id="S19" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S19title">Discussion</h2><p id="P24" class="p p-first">In the current study, we took advantage of the extensive genomic data that we have already obtained for 283 human LCLs, together with DNA samples obtained from lung cancer patients treated with platinum-based therapy to determine whether SNPs identified during a GWAS performed with LCLs might contribute to our understanding of the drug actions of platinum compounds and the response to platinum compounds in the treatment of lung cancer. Therefore, we first conducted a GWAS for cisplatin in 283 LCLs to identify top candidate SNPs that were associated with platinum cytotoxicity <em>in vitro</em> (<a href="/pmc/articles/PMC3167019/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Table 1</a>). We then performed an association study with selected top candidate SNPs using DNA samples obtained from NSCLC and SCLC patients (<a href="/pmc/articles/PMC3167019/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), followed by functional validation of candidate genes using human lung cancer cell lines (<a href="/pmc/articles/PMC3167019/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a> and <a href="/pmc/articles/PMC3167019/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). We found that 19 SNPs were associated with OS with <em>P</em> values &lt;0.05 of either NSCLC or SCLC patients (<a href="/pmc/articles/PMC3167019/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), and that knockdown of DAPK3 and METTL6, for which expression levels were correlated with the rs11169748 and rs2440915 SNPs (<a href="/pmc/articles/PMC3167019/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>), significantly decreased cisplatin sensitivity in the lung cancer cell lines H1437, H1299 and H196 (<a href="/pmc/articles/PMC3167019/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="P56">Fifteen candidate genes selected for functional validation.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140322406731648" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="left"></th><th colspan="2" rowspan="1" align="center">Basis for selection</th><th colspan="2" rowspan="1" align="center">SNP <em>vs.</em> expression in LCLs</th></tr><tr><th colspan="6" rowspan="1" valign="bottom" align="center"><hr></th></tr><tr><th rowspan="1" colspan="1" valign="top" align="left">Gene</th><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" align="center">Distance from the<br>SNP (&lt; 200 kb)</th><th rowspan="1" colspan="1" align="center">Expression associated<br>with the SNP in LCLs</th><th rowspan="1" colspan="1" valign="top" align="center"><em>R</em> value</th><th rowspan="1" colspan="1" valign="top" align="center"><em>P</em> value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">DAZAP2</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">NA<sup>a</sup></td><td rowspan="1" colspan="1" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" align="left">TFCP2</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" align="left">LETMD1</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" align="left">GALNT6</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" align="left">DAPK3</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center">0.293</td><td rowspan="1" colspan="1" align="center">1.05E-06</td></tr><tr><td rowspan="1" colspan="1" align="left">EML3</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center">0.31</td><td rowspan="1" colspan="1" align="center">2.22E-07</td></tr><tr><td rowspan="1" colspan="1" align="left">LRIG1</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center">0.273</td><td rowspan="1" colspan="1" align="center">5.66E-06</td></tr><tr><td rowspan="1" colspan="1" align="left">NENF</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center">0.292</td><td rowspan="1" colspan="1" align="center">1.15E-06</td></tr><tr><td rowspan="1" colspan="1" align="left">RUFY1</td><td rowspan="1" colspan="1" align="left">rs11169748</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center">0.301</td><td rowspan="1" colspan="1" align="center">4.92E-07</td></tr><tr><td rowspan="1" colspan="1" align="left">CCDC6</td><td rowspan="1" colspan="1" align="left">rs2440915</td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" align="left">METTL6</td><td rowspan="1" colspan="1" align="left">rs2440915</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center">0.267</td><td rowspan="1" colspan="1" align="center">9.64E-06</td></tr><tr><td rowspan="1" colspan="1" align="left">FMR1</td><td rowspan="1" colspan="1" align="left">rs5952066</td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" align="left">ELOVL5</td><td rowspan="1" colspan="1" align="left">rs5952066</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center">0.278</td><td rowspan="1" colspan="1" align="center">3.75E-06</td></tr><tr><td rowspan="1" colspan="1" align="left">METTL9</td><td rowspan="1" colspan="1" align="left">rs5952066</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center">0.250<sup>b</sup></td><td rowspan="1" colspan="1" align="center">3.57E-05</td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">0.261</td><td rowspan="1" colspan="1" align="center">1.53E-05</td></tr><tr><td rowspan="1" colspan="1" align="left">ETV5</td><td rowspan="1" colspan="1" align="left">rs7620841</td><td rowspan="1" colspan="1" align="center">Yes</td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td></tr></tbody></table></div><div id="largeobj_idm140322406731648" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3167019/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN5"><sup>a</sup>The gene is located within 200 kb up or downstream of the SNP, and no cis-regulation was identified.</div><div id="TFN6"><p id="P58" class="p p-first-last">NA, no association between the gene and SNP.</p></div><div id="TFN7"><sup>b</sup>Two probesets were associated with this SNP.</div></div></div><p id="P25">Previous candidate gene and candidate pathway-based pharmacogenomic analyses have shown that genetic variation may play a role in determining response to platinum-based chemotherapy. Much of the focus has been on SNPs within the DNA damage and repair pathway (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523655">2</a>–<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523670">4</a>, <a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523662">11</a>–<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523664">17</a>, <a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523691">32</a>). However, those results remain controversial. For example, Zhou <em>et al.</em> reported that the ERCC1 8092C&gt;A variant allele was associated with a 50% increased risk of death in Stage III (A+B) and IV NSCLC patients (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523668">32</a>), while Wu <em>et al.</em> observed that the variant A allele was significantly associated with a shorter OS (HR = 0.68, 95%CI. 0.48–0.95) (<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523696">3</a>). These previous studies indicate that the effects of each individual SNP are modest and suggest that additional SNPs/genes and/or other possible genetic mechanisms such as CpG methylation or copy number variation might influence response to platinum-based therapy.</p><p id="P26">With advances in genotyping and gene expression technologies, several studies have taken an unbiased approach towards understanding genetic factors influencing response to platinum-based chemotherapy. In LCLs obtained from pedigrees of Centr d’Etudes du polymorphism Human (CEPH) individuals of European background, it was estimated that 30–40% of the variation in cisplatin-induced cytotoxicity was due to heritable factors (<a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523701">33</a>, <a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523695">34</a>). Using this cell line model system, those investigators subsequently identified several genetic variants that contributed to cisplatin and carboplatin cytotoxicity (<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523660">24</a>, <a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523676">34</a>–<a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523689">36</a>). However, the results of those studies have not been replicated in cancer patients treated with platinum-based chemotherapeutics. Our genome-wide pharmacogenomics analysis did not confirm those variants associated with response to cisplatin (<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523682">24</a>). The difference could be due to differences between populations from which these LCLs are derived. In Huang’s study, the LCLs derived from CEU, European descent and YRI, African descent while our LCLs derived from CA, AA and HCA. It could also be due to confounding factors associated with the use of LCLs, such as cell growth rate and ATP levels (<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_313438938">37</a>). Therefore, we performed siRNA screening for selected candidate genes to pursue the underlying biology. Several previous studies have suggested an important contribution of <em>trans</em>-acting variants to individual variation in human gene expression (<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523702">38</a>, <a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523681">39</a>). Among the genes tested, knockdown of DAPK3 and METTL6, for which expression levels correlated with the rs11169748 and rs2440915 SNPs, significantly decreased cisplatin sensitivity in three lung cancer cell lines, although METTL6 expression levels were not significantly associated with cisplatin IC50 in LCLs, suggesting a potential difference between LCLs and lung cancer cell lines.</p><p id="P27">DAPK3, also known as zipper interacting protein kinase (ZIPK) or DAPK like kinase (DLK), is a member of the DAPK family. DAPK was initially identified as being encoded by a gene whose reduced expression, mediated by antisense cDNA transfection, protected HeLa cells from gamma interferon-induced cell death. DAPK3 contains several putative nuclear localization signal sequences and a leucine zipper domain, required for homo-oligomerization, interaction with other leucine zipper-containing proteins and for its death-promoting effects (<a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523659">40</a>, <a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523690">41</a>). DAPK3 has been shown to play distinct roles in tumor suppression and the regulation of apoptosis (<a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523672">42</a>–<a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523667">44</a>). We have shown that knockdown of DAPK3 significantly decreased cisplatin sensitivity in lung cancer cell lines and might be related to OS of NSCLC patients treated with platinum-based therapy.</p><p id="P28">METTL6 belongs to the methyltransferase superfamily. It has been suggested that chemoresistance and toxicity associated with platinum compound treatment might be mediated through methylation-dependent gene silencing. For example, methylation of FANCF, a gene associated with Fanconi anemia, confers cisplatin sensitivity in ovarian cancer cell lines (<a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523661">45</a>). Additionally, Ramirez <em>et al.</em> observed that 14-3-3ơ, a cell cycle checkpoint gene, is methylated in one third of NSCLC patients and that methylation is related to better median OS for these patients (<a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_231523666">46</a>). It is possible that METTL6 might influence DNA methylation, and further influence response to platinum-based therapy.</p><p id="P29" class="p">In summary, we have identified several genetic variants that are potentially associated with the efficacy of platinum-based chemotherapy in patients with lung cancer by using genome-wide interrogation of LCLs together with genotyping studies using DNA samples from lung cancer patients, followed by functional validation in lung cancer cells. Our results provide important insight into novel genes and mechanisms that may contribute to variation in response to platinum drug therapy. Most of our patients with advanced NSCLC were treated with cisplatin combination therapy, often with the addition of other chemotherapeutics, radiation or surgery. Even though the SNPs that we tested were selected based on their association with cisplatin cytotoxicity in LCLs, we can not exclude the possibility of potential interaction of genetic variation with other treatments and their effect on cisplatin treatment outcome in patients with lung cancer. Therefore, it is particularly important that our functional studies confirmed the functional effects of these genes in cisplatin response <em>in vitro</em>. Obviously, additional replication studies in independent sample sets of patients with lung cancer treated with platinum-based chemotherapy would be required to further confirm these findings.</p><div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="idm140322449255952title">Translational Relevance</h3></div><p id="P30">Chemotherapy with platinum-based regimens is the standard of care for both small cell and non-small cell lung cancer, but large inter-individual variations are observed in platinum efficacy and toxicity. However, reliable genetic biomarkers for the prediction of response to platinum-based therapy are still not well established. Our study identified several genetic variants that are potentially associated with the efficacy of platinum-based chemotherapy in patients with lung cancer by using genome-wide analysis of data generated with lymphoblastoid cell lines followed by genotyping studies using DNA samples from lung cancer patients, and functional validation in lung cancer cells. These results provide important insight into mechanisms that might contribute to variation in response to platinum-based therapy of lung cancer.</p></div></div><div id="SM" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="SMtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="N0x9e94d50N0xaf8cc80"><a href="/pmc/articles/PMC3167019/bin/NIHMS313367-supplement-1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(158K, pdf)</sup></div></div></div><div id="S20" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S20title">Acknowledgements</h2><div class="sec"><p id="P46">We thank Luanne Wussow for her assistance with the preparation of this manuscript.</p></div></div><div id="idm140322408942144" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140322408942144title">Abbreviations used</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>GWAS</td><td>genome-wide association study</td></tr><tr><td>LCLs</td><td>lymphoblastoid cell lines</td></tr><tr><td>SCLC</td><td>small cell lung cancer</td></tr><tr><td>NSCLC</td><td>non-small cell lung cancer</td></tr><tr><td>OS</td><td>overall survival</td></tr><tr><td>SNPs</td><td>single-nucleotide polymorphisms</td></tr><tr><td>AA</td><td>African-American</td></tr><tr><td>CA</td><td>Caucasian-American</td></tr><tr><td>HCA</td><td>Han Chinese-American</td></tr><tr><td>DMSO</td><td>dimethyl sulfoxide</td></tr><tr><td>HWE</td><td>Hardy-Weinberg Equilibrium</td></tr><tr><td>MAF</td><td>minor allele frequency</td></tr><tr><td>HR</td><td>hazard ratio</td></tr></tbody></table></div></div></div><div id="idm140322406233760" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140322406233760title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"><sup>†</sup>Sources of Support: This study was supported by U.S. National Institutes of Health research grants, R01 CA80127 (to PY), R01 CA84354 (to PY), K22 CA130828 (to LW), R01 CA138461 (to LW), R25T CA92049 (to XT) and U19 GM61388 (The Pharmacogenomics Research Network), Mayo Foundation funds (to PY), ASPET-Astellas Award (to LW) and a PhRMA Foundation “Center of Excellence in Clinical Pharmacology” Award (to LW)</p><p class="fn sec" id="FN2"><sup>‡</sup> Author disclosures: no conflicts of interest.</p></div></div><div id="idm140322450175264" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140322450175264title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. <span><span class="ref-journal">BMJ. </span>1995;<span class="ref-vol">311</span>:899–909.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2550915/">PMC free article</a>]</span> [<a href="/pubmed/7580546" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Chemotherapy+in+non-small+cell+lung+cancer:+a+meta-analysis+using+updated+data+on+individual+patients+from+52+randomised+clinical+trials.+Non-small+Cell+Lung+Cancer+Collaborative+Group&amp;volume=311&amp;publication_year=1995&amp;pages=899-909&amp;pmid=7580546&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, et al.  XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. <span><span class="ref-journal">J Clin Oncol. </span>2004;<span class="ref-vol">22</span>:2594–2601.</span> [<a href="/pubmed/15173214" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=XPD+and+XRCC1+genetic+polymorphisms+are+prognostic+factors+in+advanced+non-small-cell+lung+cancer+patients+treated+with+platinum+chemotherapy&amp;author=S+Gurubhagavatula&amp;author=G+Liu&amp;author=S+Park&amp;author=W+Zhou&amp;author=L+Su&amp;volume=22&amp;publication_year=2004&amp;pages=2594-2601&amp;pmid=15173214&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Wu X, Lu C, Ye Y, Chang J, Yang H, Lin J, et al.  Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2008;<span class="ref-vol">18</span>:955–965.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2665725/">PMC free article</a>]</span> [<a href="/pubmed/18854777" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=Germline+genetic+variations+in+drug+action+pathways+predict+clinical+outcomes+in+advanced+lung+cancer+treated+with+platinum-based+chemotherapy&amp;author=X+Wu&amp;author=C+Lu&amp;author=Y+Ye&amp;author=J+Chang&amp;author=H+Yang&amp;volume=18&amp;publication_year=2008&amp;pages=955-965&amp;pmid=18854777&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, et al.  Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis. <span><span class="ref-journal">Med Oncol. </span>2010;<span class="ref-vol">28</span>:315–321.</span> [<a href="/pubmed/20143185" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Oncol&amp;title=Predictive+value+of+ERCC1+and+XPD+polymorphism+in+patients+with+advanced+non-small+cell+lung+cancer+receiving+platinum-based+chemotherapy:+a+systematic+review+and+meta-analysis&amp;author=SZ+Wei&amp;author=P+Zhan&amp;author=MQ+Shi&amp;author=Y+Shi&amp;author=Q+Qian&amp;volume=28&amp;publication_year=2010&amp;pages=315-321&amp;pmid=20143185&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Huang RS, Ratain MJ. Pharmacogenetics and pharmacogenomics of anticancer agents. <span><span class="ref-journal">CA Cancer J Clin. </span>2009;<span class="ref-vol">59</span>:42–55.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3109906/">PMC free article</a>]</span> [<a href="/pubmed/19147868" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CA+Cancer+J+Clin&amp;title=Pharmacogenetics+and+pharmacogenomics+of+anticancer+agents&amp;author=RS+Huang&amp;author=MJ+Ratain&amp;volume=59&amp;publication_year=2009&amp;pages=42-55&amp;pmid=19147868&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Marsh S, McLeod H, Dolan E, Shukla SJ, Rabik CA, Gong L, et al.  Platinum pathway. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2009;<span class="ref-vol">19</span>:563–564.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4153753/">PMC free article</a>]</span> [<a href="/pubmed/19525887" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=Platinum+pathway&amp;author=S+Marsh&amp;author=H+McLeod&amp;author=E+Dolan&amp;author=SJ+Shukla&amp;author=CA+Rabik&amp;volume=19&amp;publication_year=2009&amp;pages=563-564&amp;pmid=19525887&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Rabik CA, Maryon EB, Kasza K, Shafer JT, Bartnik CM, Dolan ME. Role of copper transporters in resistance to platinating agents. <span><span class="ref-journal">Cancer Chemother Pharmacol. </span>2009;<span class="ref-vol">64</span>:133–142.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2733887/">PMC free article</a>]</span> [<a href="/pubmed/18998134" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Chemother+Pharmacol&amp;title=Role+of+copper+transporters+in+resistance+to+platinating+agents&amp;author=CA+Rabik&amp;author=EB+Maryon&amp;author=K+Kasza&amp;author=JT+Shafer&amp;author=CM+Bartnik&amp;volume=64&amp;publication_year=2009&amp;pages=133-142&amp;pmid=18998134&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Booton R, Ward T, Heighway J, Ashcroft L, Morris J, Thatcher N. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer. <span><span class="ref-journal">J Thorac Oncol. </span>2006;<span class="ref-vol">1</span>:679–683.</span> [<a href="/pubmed/17409936" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Thorac+Oncol&amp;title=Glutathione-S-transferase+P1+isoenzyme+polymorphisms,+platinum-based+chemotherapy,+and+non-small+cell+lung+cancer&amp;author=R+Booton&amp;author=T+Ward&amp;author=J+Heighway&amp;author=L+Ashcroft&amp;author=J+Morris&amp;volume=1&amp;publication_year=2006&amp;pages=679-683&amp;pmid=17409936&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Lu C, Spitz MR, Zhao H, Dong Q, Truong M, Chang JY, et al.  Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. <span><span class="ref-journal">Cancer. </span>2006;<span class="ref-vol">106</span>:441–447.</span> [<a href="/pubmed/16342067" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Association+between+glutathione+S-transferase+pi+polymorphisms+and+survival+in+patients+with+advanced+nonsmall+cell+lung+carcinoma&amp;author=C+Lu&amp;author=MR+Spitz&amp;author=H+Zhao&amp;author=Q+Dong&amp;author=M+Truong&amp;volume=106&amp;publication_year=2006&amp;pages=441-447&amp;pmid=16342067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Moyer AM, Sun Z, Batzler AJ, Li L, Schaid DJ, Yang P, et al.  Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2010;<span class="ref-vol">19</span>:811–821.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2837367/">PMC free article</a>]</span> [<a href="/pubmed/20200426" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Glutathione+pathway+genetic+polymorphisms+and+lung+cancer+survival+after+platinum-based+chemotherapy&amp;author=AM+Moyer&amp;author=Z+Sun&amp;author=AJ+Batzler&amp;author=L+Li&amp;author=DJ+Schaid&amp;volume=19&amp;publication_year=2010&amp;pages=811-821&amp;pmid=20200426&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Kim HT, Lee JE, Shin ES, Yoo YK, Cho JH, Yun MH, et al.  Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>:5972–5979.</span> [<a href="/pubmed/19018088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Effect+of+BRCA1+haplotype+on+survival+of+non-small-cell+lung+cancer+patients+treated+with+platinum-based+chemotherapy&amp;author=HT+Kim&amp;author=JE+Lee&amp;author=ES+Shin&amp;author=YK+Yoo&amp;author=JH+Cho&amp;volume=26&amp;publication_year=2008&amp;pages=5972-5979&amp;pmid=19018088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Li F, Sun X, Sun N, Qin S, Cheng H, Feng J, et al.  Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer. <span><span class="ref-journal">Am J Clin Oncol. </span>2010;<span class="ref-vol">33</span>:489–494.</span> [<a href="/pubmed/20351547" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Oncol&amp;title=Association+between+polymorphisms+of+ERCC1+and+XPD+and+clinical+response+to+platinum-based+chemotherapy+in+advanced+non-small+cell+lung+cancer&amp;author=F+Li&amp;author=X+Sun&amp;author=N+Sun&amp;author=S+Qin&amp;author=H+Cheng&amp;volume=33&amp;publication_year=2010&amp;pages=489-494&amp;pmid=20351547&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Liu L, Yuan P, Wu C, Zhang X, Wang F, Guo H, et al.  Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. <span><span class="ref-journal">Lung Cancer. </span>2011;<span class="ref-vol">73</span>:110–115.</span> [<a href="/pubmed/21129812" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lung+Cancer&amp;title=Assessment+of+XPD+Lys751Gln+and+XRCC1+T-77C+polymorphisms+in+advanced+non-small-cell+lung+cancer+patients+treated+with+platinum-based+chemotherapy&amp;author=L+Liu&amp;author=P+Yuan&amp;author=C+Wu&amp;author=X+Zhang&amp;author=F+Wang&amp;volume=73&amp;publication_year=2011&amp;pages=110-115&amp;pmid=21129812&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Matakidou A, el Galta R, Webb EL, Rudd MF, Bridle H, Eisen T, et al.  Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:2333–2340.</span> [<a href="/pubmed/17855454" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Genetic+variation+in+the+DNA+repair+genes+is+predictive+of+outcome+in+lung+cancer&amp;author=A+Matakidou&amp;author=R+el+Galta&amp;author=EL+Webb&amp;author=MF+Rudd&amp;author=H+Bridle&amp;volume=16&amp;publication_year=2007&amp;pages=2333-2340&amp;pmid=17855454&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Shiraishi K, Kohno T, Tanai C, Goto Y, Kuchiba A, Yamamoto S, et al.  Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer. <span><span class="ref-journal">J Clin Oncol. </span>2010;<span class="ref-vol">28</span>:4945–4952.</span> [<a href="/pubmed/20940192" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Association+of+DNA+repair+gene+polymorphisms+with+response+to+platinum-based+doublet+chemotherapy+in+patients+with+non-small-cell+lung+cancer&amp;author=K+Shiraishi&amp;author=T+Kohno&amp;author=C+Tanai&amp;author=Y+Goto&amp;author=A+Kuchiba&amp;volume=28&amp;publication_year=2010&amp;pages=4945-4952&amp;pmid=20940192&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Sun X, Li F, Sun N, Shukui Q, Baoan C, Jifeng F, et al.  Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients. <span><span class="ref-journal">Lung Cancer. </span>2009;<span class="ref-vol">65</span>:230–236.</span> [<a href="/pubmed/19157633" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lung+Cancer&amp;title=Polymorphisms+in+XRCC1+and+XPG+and+response+to+platinum-based+chemotherapy+in+advanced+non-small+cell+lung+cancer+patients&amp;author=X+Sun&amp;author=F+Li&amp;author=N+Sun&amp;author=Q+Shukui&amp;author=C+Baoan&amp;volume=65&amp;publication_year=2009&amp;pages=230-236&amp;pmid=19157633&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Tibaldi C, Giovannetti E, Vasile E, Mey V, Laan AC, Nannizzi S, et al.  Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. <span><span class="ref-journal">Clin Cancer Res. </span>2008;<span class="ref-vol">14</span>:1797–1803.</span> [<a href="/pubmed/18347182" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Correlation+of+CDA,+ERCC1,+and+XPD+polymorphisms+with+response+and+survival+in+gemcitabine/cisplatin-treated+advanced+non-small+cell+lung+cancer+patients&amp;author=C+Tibaldi&amp;author=E+Giovannetti&amp;author=E+Vasile&amp;author=V+Mey&amp;author=AC+Laan&amp;volume=14&amp;publication_year=2008&amp;pages=1797-1803&amp;pmid=18347182&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG, et al.  Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>1999;<span class="ref-vol">8</span>:461–465.</span> [<a href="/pubmed/10350443" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Alpha1-antitrypsin+deficiency+allele+carriers+among+lung+cancer+patients&amp;author=P+Yang&amp;author=KA+Wentzlaff&amp;author=JA+Katzmann&amp;author=RS+Marks&amp;author=MS+Allen&amp;volume=8&amp;publication_year=1999&amp;pages=461-465&amp;pmid=10350443&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Yang P, Bamlet WR, Sun Z, Ebbert JO, Aubry MC, Krowka MJ, et al.  Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. <span><span class="ref-journal">Chest. </span>2005;<span class="ref-vol">128</span>:445–452.</span> [<a href="/pubmed/16002971" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Alpha1-antitrypsin+and+neutrophil+elastase+imbalance+and+lung+cancer+risk&amp;author=P+Yang&amp;author=WR+Bamlet&amp;author=Z+Sun&amp;author=JO+Ebbert&amp;author=MC+Aubry&amp;volume=128&amp;publication_year=2005&amp;pages=445-452&amp;pmid=16002971&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, Wampfler JA, et al.  Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. <span><span class="ref-journal">Arch Intern Med. </span>2008;<span class="ref-vol">168</span>:1097–1103.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2562773/">PMC free article</a>]</span> [<a href="/pubmed/18504338" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;title=Alpha1-antitrypsin+deficiency+carriers,+tobacco+smoke,+chronic+obstructive+pulmonary+disease,+and+lung+cancer+risk&amp;author=P+Yang&amp;author=Z+Sun&amp;author=MJ+Krowka&amp;author=MC+Aubry&amp;author=WR+Bamlet&amp;volume=168&amp;publication_year=2008&amp;pages=1097-1103&amp;pmid=18504338&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Li L, Fridley B, Kalari K, Jenkins G, Batzler A, Safgren S, et al.  Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. <span><span class="ref-journal">Cancer Res. </span>2008;<span class="ref-vol">68</span>:7050–7058.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2562356/">PMC free article</a>]</span> [<a href="/pubmed/18757419" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Gemcitabine+and+cytosine+arabinoside+cytotoxicity:+association+with+lymphoblastoid+cell+expression&amp;author=L+Li&amp;author=B+Fridley&amp;author=K+Kalari&amp;author=G+Jenkins&amp;author=A+Batzler&amp;volume=68&amp;publication_year=2008&amp;pages=7050-7058&amp;pmid=18757419&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Li L, Fridley BL, Kalari K, Jenkins G, Batzler A, Weinshilboum RM, et al.  Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4</span>:e7765.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2770319/">PMC free article</a>]</span> [<a href="/pubmed/19898621" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Gemcitabine+and+arabinosylcytosin+pharmacogenomics:+genome-wide+association+and+drug+response+biomarkers&amp;author=L+Li&amp;author=BL+Fridley&amp;author=K+Kalari&amp;author=G+Jenkins&amp;author=A+Batzler&amp;volume=4&amp;publication_year=2009&amp;pages=e7765&amp;pmid=19898621&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, Zhu M, et al.  Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. <span><span class="ref-journal">Genome Res. </span>2010;<span class="ref-vol">20</span>:1482–1492.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2963812/">PMC free article</a>]</span> [<a href="/pubmed/20923822" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Radiation+pharmacogenomics:+a+genome-wide+association+approach+to+identify+radiation+response+biomarkers+using+human+lymphoblastoid+cell+lines&amp;author=N+Niu&amp;author=Y+Qin&amp;author=BL+Fridley&amp;author=J+Hou&amp;author=KR+Kalari&amp;volume=20&amp;publication_year=2010&amp;pages=1482-1492&amp;pmid=20923822&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX, et al.  Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:427–437.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950832/">PMC free article</a>]</span> [<a href="/pubmed/17701890" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Identification+of+genetic+variants+contributing+to+cisplatin-induced+cytotoxicity+by+use+of+a+genomewide+approach&amp;author=RS+Huang&amp;author=S+Duan&amp;author=SJ+Shukla&amp;author=EO+Kistner&amp;author=TA+Clark&amp;volume=81&amp;publication_year=2007&amp;pages=427-437&amp;pmid=17701890&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:887–893.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1199378/">PMC free article</a>]</span> [<a href="/pubmed/15789306" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=A+note+on+exact+tests+of+Hardy-Weinberg+equilibrium&amp;author=JE+Wigginton&amp;author=DJ+Cutler&amp;author=GR+Abecasis&amp;volume=76&amp;publication_year=2005&amp;pages=887-893&amp;pmid=15789306&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Schaid DJ, Batzler AJ, Jenkins GD, Hildebrandt MA. Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:1071–1080.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1698709/">PMC free article</a>]</span> [<a href="/pubmed/17186465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Exact+tests+of+Hardy-Weinberg+equilibrium+and+homogeneity+of+disequilibrium+across+strata&amp;author=DJ+Schaid&amp;author=AJ+Batzler&amp;author=GD+Jenkins&amp;author=MA+Hildebrandt&amp;volume=79&amp;publication_year=2006&amp;pages=1071-1080&amp;pmid=17186465&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">447</span>:661–678.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2719288/">PMC free article</a>]</span> [<a href="/pubmed/17554300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genome-wide+association+study+of+14,000+cases+of+seven+common+diseases+and+3,000+shared+controls&amp;volume=447&amp;publication_year=2007&amp;pages=661-678&amp;pmid=17554300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Pongpanich M, Sullivan PF, Tzeng JY. A quality control algorithm for filtering SNPs in genome-wide association studies. <span><span class="ref-journal">Bioinformatics. </span>2010;<span class="ref-vol">26</span>:1731–1737.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2894516/">PMC free article</a>]</span> [<a href="/pubmed/20501555" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=A+quality+control+algorithm+for+filtering+SNPs+in+genome-wide+association+studies&amp;author=M+Pongpanich&amp;author=PF+Sullivan&amp;author=JY+Tzeng&amp;volume=26&amp;publication_year=2010&amp;pages=1731-1737&amp;pmid=20501555&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:904–909.</span> [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=AL+Price&amp;author=NJ+Patterson&amp;author=RM+Plenge&amp;author=ME+Weinblatt&amp;author=NA+Shadick&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. <span><span class="ref-journal">Genet Epidemiol. </span>2010;<span class="ref-vol">34</span>:816–834.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3175618/">PMC free article</a>]</span> [<a href="/pubmed/21058334" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genet+Epidemiol&amp;title=MaCH:+using+sequence+and+genotype+data+to+estimate+haplotypes+and+unobserved+genotypes&amp;author=Y+Li&amp;author=CJ+Willer&amp;author=J+Ding&amp;author=P+Scheet&amp;author=GR+Abecasis&amp;volume=34&amp;publication_year=2010&amp;pages=816-834&amp;pmid=21058334&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, Gibbs RA, et al.  A map of human genome variation from population-scale sequencing. <span><span class="ref-journal">Nature. </span>2010;<span class="ref-vol">467</span>:1061–1073.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3042601/">PMC free article</a>]</span> [<a href="/pubmed/20981092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+map+of+human+genome+variation+from+population-scale+sequencing&amp;author=RM+Durbin&amp;author=GR+Abecasis&amp;author=DL+Altshuler&amp;author=A+Auton&amp;author=LD+Brooks&amp;volume=467&amp;publication_year=2010&amp;pages=1061-1073&amp;pmid=20981092&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, et al.  Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. <span><span class="ref-journal">Clin Cancer Res. </span>2004;<span class="ref-vol">10</span>:4939–4943.</span> [<a href="/pubmed/15297394" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Excision+repair+cross-complementation+group+1+polymorphism+predicts+overall+survival+in+advanced+non-small+cell+lung+cancer+patients+treated+with+platinum-based+chemotherapy&amp;author=W+Zhou&amp;author=S+Gurubhagavatula&amp;author=G+Liu&amp;author=S+Park&amp;author=DS+Neuberg&amp;volume=10&amp;publication_year=2004&amp;pages=4939-4943&amp;pmid=15297394&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Dolan ME, Newbold KG, Nagasubramanian R, Wu X, Ratain MJ, Cook EH, Jr, et al.  Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity. <span><span class="ref-journal">Cancer Res. </span>2004;<span class="ref-vol">64</span>:4353–4356.</span> [<a href="/pubmed/15205351" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Heritability+and+linkage+analysis+of+sensitivity+to+cisplatin-induced+cytotoxicity&amp;author=ME+Dolan&amp;author=KG+Newbold&amp;author=R+Nagasubramanian&amp;author=X+Wu&amp;author=MJ+Ratain&amp;volume=64&amp;publication_year=2004&amp;pages=4353-4356&amp;pmid=15205351&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Shukla SJ, Duan S, Badner JA, Wu X, Dolan ME. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2008;<span class="ref-vol">18</span>:253–262.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2567113/">PMC free article</a>]</span> [<a href="/pubmed/18300947" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=Susceptibility+loci+involved+in+cisplatin-induced+cytotoxicity+and+apoptosis&amp;author=SJ+Shukla&amp;author=S+Duan&amp;author=JA+Badner&amp;author=X+Wu&amp;author=ME+Dolan&amp;volume=18&amp;publication_year=2008&amp;pages=253-262&amp;pmid=18300947&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Huang RS, Duan S, Kistner EO, Hartford CM, Dolan ME. Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. <span><span class="ref-journal">Mol Cancer Ther. </span>2008;<span class="ref-vol">7</span>:3038–3046.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2743011/">PMC free article</a>]</span> [<a href="/pubmed/18765826" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=Genetic+variants+associated+with+carboplatin-induced+cytotoxicity+in+cell+lines+derived+from+Africans&amp;author=RS+Huang&amp;author=S+Duan&amp;author=EO+Kistner&amp;author=CM+Hartford&amp;author=ME+Dolan&amp;volume=7&amp;publication_year=2008&amp;pages=3038-3046&amp;pmid=18765826&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Shukla SJ, Duan S, Wu X, Badner JA, Kasza K, Dolan ME. Whole-genome approach implicates CD44 in cellular resistance to carboplatin. <span><span class="ref-journal">Hum Genomics. </span>2009;<span class="ref-vol">3</span>:128–142.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2683878/">PMC free article</a>]</span> [<a href="/pubmed/19164090" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Genomics&amp;title=Whole-genome+approach+implicates+CD44+in+cellular+resistance+to+carboplatin&amp;author=SJ+Shukla&amp;author=S+Duan&amp;author=X+Wu&amp;author=JA+Badner&amp;author=K+Kasza&amp;volume=3&amp;publication_year=2009&amp;pages=128-142&amp;pmid=19164090&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Choy E, Yelensky R, Bonakdar S, Plenge RM, Saxena R, De Jager PL, et al.  Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. <span><span class="ref-journal">PLoS Genet. </span>2008;<span class="ref-vol">4</span></span> e1000287. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2583954/">PMC free article</a>]</span> [<a href="/pubmed/19043577" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Genetic+analysis+of+human+traits+in+vitro:+drug+response+and+gene+expression+in+lymphoblastoid+cell+lines&amp;author=E+Choy&amp;author=R+Yelensky&amp;author=S+Bonakdar&amp;author=RM+Plenge&amp;author=R+Saxena&amp;volume=4&amp;publication_year=2008&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, et al.  Genetic analysis of genome-wide variation in human gene expression. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">430</span>:743–747.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2966974/">PMC free article</a>]</span> [<a href="/pubmed/15269782" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genetic+analysis+of+genome-wide+variation+in+human+gene+expression&amp;author=M+Morley&amp;author=CM+Molony&amp;author=TM+Weber&amp;author=JL+Devlin&amp;author=KG+Ewens&amp;volume=430&amp;publication_year=2004&amp;pages=743-747&amp;pmid=15269782&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, et al.  Genetics of gene expression and its effect on disease. <span><span class="ref-journal">Nature. </span>2008;<span class="ref-vol">452</span>:423–428.</span> [<a href="/pubmed/18344981" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genetics+of+gene+expression+and+its+effect+on+disease&amp;author=V+Emilsson&amp;author=G+Thorleifsson&amp;author=B+Zhang&amp;author=AS+Leonardson&amp;author=F+Zink&amp;volume=452&amp;publication_year=2008&amp;pages=423-428&amp;pmid=18344981&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S. ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. <span><span class="ref-journal">Mol Cell Biol. </span>1998;<span class="ref-vol">18</span>:1642–1651.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC108879/">PMC free article</a>]</span> [<a href="/pubmed/9488481" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=ZIP+kinase,+a+novel+serine/threonine+kinase+which+mediates+apoptosis&amp;author=T+Kawai&amp;author=M+Matsumoto&amp;author=K+Takeda&amp;author=H+Sanjo&amp;author=S+Akira&amp;volume=18&amp;publication_year=1998&amp;pages=1642-1651&amp;pmid=9488481&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Shoval Y, Pietrokovski S, Kimchi A. ZIPK: a unique case of murine-specific divergence of a conserved vertebrate gene. <span><span class="ref-journal">PLoS Genet. </span>2007;<span class="ref-vol">3</span>:1884–1893.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2041995/">PMC free article</a>]</span> [<a href="/pubmed/17953487" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=ZIPK:+a+unique+case+of+murine-specific+divergence+of+a+conserved+vertebrate+gene&amp;author=Y+Shoval&amp;author=S+Pietrokovski&amp;author=A+Kimchi&amp;volume=3&amp;publication_year=2007&amp;pages=1884-1893&amp;pmid=17953487&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Raveh T, Kimchi A. DAP kinase-a proapoptotic gene that functions as a tumor suppressor. <span><span class="ref-journal">Exp Cell Res. </span>2001;<span class="ref-vol">264</span>:185–192.</span> [<a href="/pubmed/11237533" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Cell+Res&amp;title=DAP+kinase-a+proapoptotic+gene+that+functions+as+a+tumor+suppressor&amp;author=T+Raveh&amp;author=A+Kimchi&amp;volume=264&amp;publication_year=2001&amp;pages=185-192&amp;pmid=11237533&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Wang WJ, Kuo JC, Yao CC, Chen RH. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. <span><span class="ref-journal">J Cell Biol. </span>2002;<span class="ref-vol">159</span>:169–179.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2173490/">PMC free article</a>]</span> [<a href="/pubmed/12370243" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biol&amp;title=DAP-kinase+induces+apoptosis+by+suppressing+integrin+activity+and+disrupting+matrix+survival+signals&amp;author=WJ+Wang&amp;author=JC+Kuo&amp;author=CC+Yao&amp;author=RH+Chen&amp;volume=159&amp;publication_year=2002&amp;pages=169-179&amp;pmid=12370243&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Bialik S, Kimchi A. DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death. <span><span class="ref-journal">Semin Cancer Biol. </span>2004;<span class="ref-vol">14</span>:283–294.</span> [<a href="/pubmed/15219621" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Cancer+Biol&amp;title=DAP-kinase+as+a+target+for+drug+design+in+cancer+and+diseases+associated+with+accelerated+cell+death&amp;author=S+Bialik&amp;author=A+Kimchi&amp;volume=14&amp;publication_year=2004&amp;pages=283-294&amp;pmid=15219621&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, et al.  Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. <span><span class="ref-journal">Nat Med. </span>2003;<span class="ref-vol">9</span>:568–574.</span> [<a href="/pubmed/12692539" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Disruption+of+the+Fanconi+anemia-BRCA+pathway+in+cisplatin-sensitive+ovarian+tumors&amp;author=T+Taniguchi&amp;author=M+Tischkowitz&amp;author=N+Ameziane&amp;author=SV+Hodgson&amp;author=CG+Mathew&amp;volume=9&amp;publication_year=2003&amp;pages=568-574&amp;pmid=12692539&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">Ramirez JL, Rosell R, Taron M, Sanchez-Ronco M, Alberola V, de Las Penas R, et al.  14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group. <span><span class="ref-journal">J Clin Oncol. </span>2005;<span class="ref-vol">23</span>:9105–9112.</span> [<a href="/pubmed/16361617" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=14-3-3sigma+methylation+in+pretreatment+serum+circulating+DNA+of+cisplatin-plus-gemcitabine-treated+advanced+non-small-cell+lung+cancer+patients+predicts+survival:+The+Spanish+Lung+Cancer+Group&amp;author=JL+Ramirez&amp;author=R+Rosell&amp;author=M+Taron&amp;author=M+Sanchez-Ronco&amp;author=V+Alberola&amp;volume=23&amp;publication_year=2005&amp;pages=9105-9112&amp;pmid=16361617&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140322411152976title">Abstract</a></li><li><a href="#S5title">Introduction</a></li><li><a href="#S6title">Materials and Methods</a></li><li><a href="#S15title">Results</a></li><li><a href="#S19title">Discussion</a></li><li><a href="#SMtitle">Supplementary Material</a></li><li><a href="#S20title">Acknowledgements</a></li><li><a href="#idm140322408942144title">Abbreviations used</a></li><li><a href="#idm140322406233760title">Footnotes</a></li><li><a href="#idm140322450175264title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3167019/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3167019/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3167019/pdf/nihms313367.pdf">PDF (3.2M)</a></li> | <li><a href="#" data-citationid="PMC3167019" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3167019%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3167019%2F&amp;text=Genetic%20variation%20predicting%20cisplatin%20cytotoxicity%20associated%20with%20overall%20survival%20in%20lung%20cancer%20patients%20receiving%20platinum-based%20chemotherapy%20%2C%20" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3167019%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="21775533" data-aiid="3167019" data-aid="3167019" data-iid="199786" data-domainid="319" data-domain="nihpa" data-accid="PMC3167019" data-md5="e400410b89c174b076a7f9b9ce70d3ff">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-5" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input name="absid" id="absid" value="3167019" type="hidden"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" value="1" type="submit"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-6" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-6" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/23006423" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.</a><span class="source">[BMC Cancer. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Niu N, Schaid DJ, Abo RP, Kalari K, Fridley BL, Feng Q, Jenkins G, Batzler A, Brisbin AG, Cunningham JM, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Cancer. 2012 Sep 24; 12:422. Epub 2012 Sep 24.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/22608006" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.</a><span class="source">[Lung Cancer. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kim SH, Lee GW, Lee MJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim IS, Lee S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Lung Cancer. 2012 Sep; 77(3):578-84. Epub 2012 May 18.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/20200426" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy.</a><span class="source">[Cancer Epidemiol Biomarkers Pr...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moyer AM, Sun Z, Batzler AJ, Li L, Schaid DJ, Yang P, Weinshilboum RM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cancer Epidemiol Biomarkers Prev. 2010 Mar; 19(3):811-21. Epub 2010 Mar 3.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/25531699" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">[Single nucleotide polymorphisms in lung cancer patients and cisplatin treatment].</a><span class="source">[Postepy Hig Med Dosw (Online)....]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stenzel-Bembenek A, Sagan D, Guz M, Stepulak A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Postepy Hig Med Dosw (Online). 2014 Nov 25; 68:1361-73. Epub 2014 Nov 25.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/19442035" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacogenomics of platinum-based chemotherapy in NSCLC.</a><span class="source">[Expert Opin Drug Metab Toxicol...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-11" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hildebrandt MA, Gu J, Wu X. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Expert Opin Drug Metab Toxicol. 2009 Jul; 5(7):745-55. </em>
</div>
</li>
</ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21775533&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21775533&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-12" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-12" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6531706/" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Outcomes comparison between neoadjuvant chemotherapy and adjuvant chemotherapy in stage IIIA non-small cell lung cancer patients</a><span class="source">[Journal of Thoracic Disease. 2...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tao X, Yuan C, Zheng D, Ye T, Pan Y, Zhang Y, Xiang J, Hu H, Chen H, Sun Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Journal of Thoracic Disease. 2019 Apr; 11(4): 1443-1455</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6412123/" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Matching tRNA modifications in humans to their known and predicted enzymes</a><span class="source">[Nucleic Acids Research. 2019]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">de&nbsp;Crécy-Lagard V, Boccaletto P, Mangleburg CG, Sharma P, Lowe TM, Leidel SA, Bujnicki JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Nucleic Acids Research. 2019 Jan 30; 47(5): 2143-2159</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6362241/" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">CHD1L contributes to cisplatin resistance by upregulating the ABCB1–NF-κB axis in human non-small-cell lung cancer</a><span class="source"></span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Li Y, He LR, Gao Y, Zhou NN, Liu Y, Zhou XK, Liu JF, Guan XY, Ma NF, Xie D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cell Death &amp; Disease. 2019 Feb 4; 10(2): 99</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6245589/" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pipeline design to identify key features and classify the chemotherapy response on lung cancer patients using large-scale genetic data</a><span class="source">[BMC Systems Biology. 2018]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Valdés MG, Galván-Femenía I, Ripoll VR, Duran X, Yokota J, Gavaldà R, Rafael-Palou X, de Cid R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Systems Biology. 2018 Nov 20; 12(Suppl 5): 97</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6036442/" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Inhibitor of DNA binding 3 reverses cisplatin resistance in human lung adenocarcinoma cells by regulating the PI3K/Akt pathway</a><span class="source">[Oncology Letters. 2018]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-17" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen FF, Lv X, Zhao QF, Xu YZ, Song SS, Yu W, Li XJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Oncology Letters. 2018 May 31; 16(2): 1634-1640</em>
</div>
</li>
</ul>
<a class="seemore" href="citedby/" ref="reftype=relart&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-18" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-18" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=bioproject&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_bioproject&amp;IdsFromResult=3167019" ref="reftype=BioProject&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">BioProject</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">BioProject<div class="brieflinkpopdesc">BioProject links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=3167019" ref="reftype=Compound&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gds&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gds&amp;IdsFromResult=3167019" ref="reftype=GEO%20DataSets&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|GEO%20DataSets&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">GEO DataSets</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-21" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">GEO DataSets<div class="brieflinkpopdesc">GEO DataSet links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3167019" ref="reftype=MedGen&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-22" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pubmed/21775533/" ref="reftype=PubMed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-23" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=snp&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_snp&amp;IdsFromResult=3167019" ref="reftype=SNP&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|SNP&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">SNP</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-24" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">SNP<div class="brieflinkpopdesc">PMC to SNP links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=3167019" ref="reftype=Substance&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-25" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=3167019" ref="reftype=Taxonomy&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Taxonomy</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-26" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-27" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-27" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dd530f439a66eb03d67d169">Genetic variation predicting cisplatin cytotoxicity associated with overall surv...</a><div class="ralinkpop offscreen_noflow">Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy , <div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2011 Sep 1; 17(17)5801</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=5dd530c975f66d018f761025">Genome-wide association study for serum urate concentrations and gout among Afri...</a><div class="ralinkpop offscreen_noflow">Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele<div class="brieflinkpopdesc">Human Molecular Genetics. 2011 Oct 15; 20(20)4056</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=5dd530a0dde0893a8b777be0">Meta-analysis of New Genome-wide Association Studies of Colorectal Cancer Risk</a><div class="ralinkpop offscreen_noflow">Meta-analysis of New Genome-wide Association Studies of Colorectal Cancer Risk<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2012 Feb; 131(2)217</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=5dd53069dde0893a8b6e65f7">Association of γ′ Fibrinogen with Cardiovascular Disease</a><div class="ralinkpop offscreen_noflow">Association of γ′ Fibrinogen with Cardiovascular Disease<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2011 Oct; 31(10)2345</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=5dd5304adde0893a8b679ecb">Identification of cis and trans acting genetic variants explaining up to half th...</a><div class="ralinkpop offscreen_noflow">Identification of cis and trans acting genetic variants explaining up to half the variation in circulating VEGF levels<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2011 Aug 19; 109(5)554</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--P5" name="crb--P5" rid="P5" style="position: absolute; visibility: visible; width: 370px; top: 1431px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul>
<li class="two_line" reference_id="R1">
<a href="/pubmed/7580546/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.</a><span class="one_line_source">[BMJ.  1995]</span><div class="alt-note">
<div class="authors"></div>
<div class="citation">BMJ. 1995 Oct 7; 311(7010):899-909.</div>
</div>
</li>
<li class="two_line" reference_id="R2">
<a href="/pubmed/15173214/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.</a><span class="one_line_source">[J Clin Oncol.  2004]</span><div class="alt-note">
<div class="authors">Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC</div>
<div class="citation">J Clin Oncol. 2004 Jul 1; 22(13):2594-601.</div>
</div>
</li>
<li class="two_line" reference_id="R4">
<a href="/pubmed/20143185/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.</a><span class="one_line_source">[Med Oncol.  2011]</span><div class="alt-note">
<div class="authors">Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, Song Y</div>
<div class="citation">Med Oncol. 2011 Mar; 28(1):315-21.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P6" name="crb--P6" rid="P6" style="position: absolute; visibility: visible; width: 370px; top: 1706px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="R5">
<a href="/pubmed/19147868/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacogenetics and pharmacogenomics of anticancer agents.</a><span class="one_line_source">[CA Cancer J Clin.  2009]</span><div class="alt-note">
<div class="authors">Huang RS, Ratain MJ</div>
<div class="citation">CA Cancer J Clin. 2009 Jan-Feb; 59(1):42-55.</div>
</div>
</li>
<li class="two_line" reference_id="R6">
<a href="/pubmed/19525887/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Platinum pathway.</a><span class="one_line_source">[Pharmacogenet Genomics.  2009]</span><div class="alt-note">
<div class="authors">Marsh S, McLeod H, Dolan E, Shukla SJ, Rabik CA, Gong L, Hernandez-Boussard T, Lou XJ, Klein TE, Altman RB</div>
<div class="citation">Pharmacogenet Genomics. 2009 Jul; 19(7):563-4.</div>
</div>
</li>
<li class="two_line" reference_id="R7">
<a href="/pubmed/18998134/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Role of copper transporters in resistance to platinating agents.</a><span class="one_line_source">[Cancer Chemother Pharmacol.  2009]</span><div class="alt-note">
<div class="authors">Rabik CA, Maryon EB, Kasza K, Shafer JT, Bartnik CM, Dolan ME</div>
<div class="citation">Cancer Chemother Pharmacol. 2009 Jun; 64(1):133-42.</div>
</div>
</li>
<li class="two_line" reference_id="R8">
<a href="/pubmed/17409936/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.</a><span class="one_line_source">[J Thorac Oncol.  2006]</span><div class="alt-note">
<div class="authors">Booton R, Ward T, Heighway J, Ashcroft L, Morris J, Thatcher N</div>
<div class="citation">J Thorac Oncol. 2006 Sep; 1(7):679-83.</div>
</div>
</li>
<li class="two_line" reference_id="R10">
<a href="/pubmed/20200426/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy.</a><span class="one_line_source">[Cancer Epidemiol Biomarkers Prev.  2010]</span><div class="alt-note">
<div class="authors">Moyer AM, Sun Z, Batzler AJ, Li L, Schaid DJ, Yang P, Weinshilboum RM</div>
<div class="citation">Cancer Epidemiol Biomarkers Prev. 2010 Mar; 19(3):811-21.</div>
</div>
</li>
<li class="two_line" reference_id="R2" style="display: none;">
<a href="/pubmed/15173214/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.</a><span class="one_line_source">[J Clin Oncol.  2004]</span><div class="alt-note">
<div class="authors">Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC</div>
<div class="citation">J Clin Oncol. 2004 Jul 1; 22(13):2594-601.</div>
</div>
</li>
<li class="two_line" reference_id="R4" style="display: none;">
<a href="/pubmed/20143185/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.</a><span class="one_line_source">[Med Oncol.  2011]</span><div class="alt-note">
<div class="authors">Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, Song Y</div>
<div class="citation">Med Oncol. 2011 Mar; 28(1):315-21.</div>
</div>
</li>
<li class="two_line" reference_id="R11" style="display: none;">
<a href="/pubmed/19018088/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy.</a><span class="one_line_source">[J Clin Oncol.  2008]</span><div class="alt-note">
<div class="authors">Kim HT, Lee JE, Shin ES, Yoo YK, Cho JH, Yun MH, Kim YH, Kim SK, Kim HJ, Jang TW, Kwak SM, Kim CS, Ryu JS</div>
<div class="citation">J Clin Oncol. 2008 Dec 20; 26(36):5972-9.</div>
</div>
</li>
<li class="two_line" reference_id="R17" style="display: none;">
<a href="/pubmed/18347182/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.</a><span class="one_line_source">[Clin Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Tibaldi C, Giovannetti E, Vasile E, Mey V, Laan AC, Nannizzi S, Di Marsico R, Antonuzzo A, Orlandini C, Ricciardi S, Del Tacca M, Peters GJ, Falcone A, Danesi R</div>
<div class="citation">Clin Cancer Res. 2008 Mar 15; 14(6):1797-803.</div>
</div>
</li>
</ul><a href="" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P9" name="crb--P9" rid="P9" style="position: absolute; visibility: visible; width: 370px; top: 2433px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="R18">
<a href="/pubmed/10350443/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Alpha1-antitrypsin deficiency allele carriers among lung cancer patients.</a><span class="one_line_source">[Cancer Epidemiol Biomarkers Prev.  1999]</span><div class="alt-note">
<div class="authors">Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG, Lindor NM, Myers JL, Wiegert E, Midthun DE, Thibodeau SN, Krowka MJ</div>
<div class="citation">Cancer Epidemiol Biomarkers Prev. 1999 May; 8(5):461-5.</div>
</div>
</li>
<li class="two_line" reference_id="R20">
<a href="/pubmed/18504338/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk.</a><span class="one_line_source">[Arch Intern Med.  2008]</span><div class="alt-note">
<div class="authors">Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, Wampfler JA, Thibodeau SN, Katzmann JA, Allen MS, Midthun DE, Marks RS, de Andrade M</div>
<div class="citation">Arch Intern Med. 2008 May 26; 168(10):1097-103.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P11" name="crb--P11" rid="P11" style="position: absolute; visibility: visible; width: 370px; top: 3021px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul>
<li class="two_line" reference_id="R21">
<a href="/pubmed/18757419/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.</a><span class="one_line_source">[Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Li L, Fridley B, Kalari K, Jenkins G, Batzler A, Safgren S, Hildebrandt M, Ames M, Schaid D, Wang L</div>
<div class="citation">Cancer Res. 2008 Sep 1; 68(17):7050-8.</div>
</div>
</li>
<li class="two_line" reference_id="R23">
<a href="/pubmed/20923822/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.</a><span class="one_line_source">[Genome Res.  2010]</span><div class="alt-note">
<div class="authors">Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, Zhu M, Wu TY, Jenkins GD, Batzler A, Wang L</div>
<div class="citation">Genome Res. 2010 Nov; 20(11):1482-92.</div>
</div>
</li>
<li class="two_line" reference_id="R24">
<a href="/pubmed/17701890/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.</a><span class="one_line_source">[Am J Hum Genet.  2007]</span><div class="alt-note">
<div class="authors">Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX, Schweitzer AC, Blume JE, Dolan ME</div>
<div class="citation">Am J Hum Genet. 2007 Sep; 81(3):427-37.</div>
</div>
</li>
<li class="two_line" reference_id="R25">
<a href="/pubmed/15789306/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A note on exact tests of Hardy-Weinberg equilibrium.</a><span class="one_line_source">[Am J Hum Genet.  2005]</span><div class="alt-note">
<div class="authors">Wigginton JE, Cutler DJ, Abecasis GR</div>
<div class="citation">Am J Hum Genet. 2005 May; 76(5):887-93.</div>
</div>
</li>
<li class="two_line" reference_id="R26" style="display: none;">
<a href="/pubmed/17186465/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata.</a><span class="one_line_source">[Am J Hum Genet.  2006]</span><div class="alt-note">
<div class="authors">Schaid DJ, Batzler AJ, Jenkins GD, Hildebrandt MA</div>
<div class="citation">Am J Hum Genet. 2006 Dec; 79(6):1071-80.</div>
</div>
</li>
<li class="two_line" reference_id="R27" style="display: none;">
<a href="/pubmed/17554300/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.</a><span class="one_line_source">[Nature.  2007]</span><div class="alt-note">
<div class="authors">Wellcome Trust Case Control Consortium.</div>
<div class="citation">Nature. 2007 Jun 7; 447(7145):661-78.</div>
</div>
</li>
<li class="two_line" reference_id="R28" style="display: none;">
<a href="/pubmed/20501555/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A quality control algorithm for filtering SNPs in genome-wide association studies.</a><span class="one_line_source">[Bioinformatics.  2010]</span><div class="alt-note">
<div class="authors">Pongpanich M, Sullivan PF, Tzeng JY</div>
<div class="citation">Bioinformatics. 2010 Jul 15; 26(14):1731-7.</div>
</div>
</li>
</ul><a href="" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P16" name="crb--P16" rid="P16" style="position: absolute; visibility: visible; width: 370px; top: 4166px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="R21">
<a href="/pubmed/18757419/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.</a><span class="one_line_source">[Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Li L, Fridley B, Kalari K, Jenkins G, Batzler A, Safgren S, Hildebrandt M, Ames M, Schaid D, Wang L</div>
<div class="citation">Cancer Res. 2008 Sep 1; 68(17):7050-8.</div>
</div>
</li>
<li class="two_line" reference_id="R23">
<a href="/pubmed/20923822/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.</a><span class="one_line_source">[Genome Res.  2010]</span><div class="alt-note">
<div class="authors">Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, Zhu M, Wu TY, Jenkins GD, Batzler A, Wang L</div>
<div class="citation">Genome Res. 2010 Nov; 20(11):1482-92.</div>
</div>
</li>
<li class="two_line" reference_id="R29">
<a href="/pubmed/16862161/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Principal components analysis corrects for stratification in genome-wide association studies.</a><span class="one_line_source">[Nat Genet.  2006]</span><div class="alt-note">
<div class="authors">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D</div>
<div class="citation">Nat Genet. 2006 Aug; 38(8):904-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P22" name="crb--P22" rid="P22" style="position: absolute; visibility: visible; width: 370px; top: 8175px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul>
<li class="two_line" reference_id="R21">
<a href="/pubmed/18757419/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.</a><span class="one_line_source">[Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Li L, Fridley B, Kalari K, Jenkins G, Batzler A, Safgren S, Hildebrandt M, Ames M, Schaid D, Wang L</div>
<div class="citation">Cancer Res. 2008 Sep 1; 68(17):7050-8.</div>
</div>
</li>
<li class="two_line" reference_id="R23">
<a href="/pubmed/20923822/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.</a><span class="one_line_source">[Genome Res.  2010]</span><div class="alt-note">
<div class="authors">Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, Zhu M, Wu TY, Jenkins GD, Batzler A, Wang L</div>
<div class="citation">Genome Res. 2010 Nov; 20(11):1482-92.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P23" name="crb--P23" rid="P23" style="position: absolute; visibility: visible; width: 370px; top: 8693px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul>
<li class="two_line" reference_id="R30">
<a href="/pubmed/21058334/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes.</a><span class="one_line_source">[Genet Epidemiol.  2010]</span><div class="alt-note">
<div class="authors">Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR</div>
<div class="citation">Genet Epidemiol. 2010 Dec; 34(8):816-34.</div>
</div>
</li>
<li class="two_line" reference_id="R31">
<a href="/pubmed/20981092/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A map of human genome variation from population-scale sequencing.</a><span class="one_line_source">[Nature.  2010]</span><div class="alt-note">
<div class="authors">1000 Genomes Project Consortium., Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA</div>
<div class="citation">Nature. 2010 Oct 28; 467(7319):1061-73.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P25" name="crb--P25" rid="P25" style="position: absolute; visibility: visible; width: 370px; top: 11948px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul>
<li class="two_line" reference_id="R2">
<a href="/pubmed/15173214/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.</a><span class="one_line_source">[J Clin Oncol.  2004]</span><div class="alt-note">
<div class="authors">Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC</div>
<div class="citation">J Clin Oncol. 2004 Jul 1; 22(13):2594-601.</div>
</div>
</li>
<li class="two_line" reference_id="R4">
<a href="/pubmed/20143185/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.</a><span class="one_line_source">[Med Oncol.  2011]</span><div class="alt-note">
<div class="authors">Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, Song Y</div>
<div class="citation">Med Oncol. 2011 Mar; 28(1):315-21.</div>
</div>
</li>
<li class="two_line" reference_id="R11">
<a href="/pubmed/19018088/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy.</a><span class="one_line_source">[J Clin Oncol.  2008]</span><div class="alt-note">
<div class="authors">Kim HT, Lee JE, Shin ES, Yoo YK, Cho JH, Yun MH, Kim YH, Kim SK, Kim HJ, Jang TW, Kwak SM, Kim CS, Ryu JS</div>
<div class="citation">J Clin Oncol. 2008 Dec 20; 26(36):5972-9.</div>
</div>
</li>
<li class="two_line" reference_id="R17">
<a href="/pubmed/18347182/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.</a><span class="one_line_source">[Clin Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Tibaldi C, Giovannetti E, Vasile E, Mey V, Laan AC, Nannizzi S, Di Marsico R, Antonuzzo A, Orlandini C, Ricciardi S, Del Tacca M, Peters GJ, Falcone A, Danesi R</div>
<div class="citation">Clin Cancer Res. 2008 Mar 15; 14(6):1797-803.</div>
</div>
</li>
<li class="two_line" reference_id="R32" style="display: none;">
<a href="/pubmed/15297394/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.</a><span class="one_line_source">[Clin Cancer Res.  2004]</span><div class="alt-note">
<div class="authors">Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC</div>
<div class="citation">Clin Cancer Res. 2004 Aug 1; 10(15):4939-43.</div>
</div>
</li>
<li class="two_line" reference_id="R3" style="display: none;">
<a href="/pubmed/18854777/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.</a><span class="one_line_source">[Pharmacogenet Genomics.  2008]</span><div class="alt-note">
<div class="authors">Wu X, Lu C, Ye Y, Chang J, Yang H, Lin J, Gu J, Hong WK, Stewart D, Spitz MR</div>
<div class="citation">Pharmacogenet Genomics. 2008 Nov; 18(11):955-65.</div>
</div>
</li>
</ul><a href="" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P26" name="crb--P26" rid="P26" style="position: absolute; visibility: visible; width: 370px; top: 12158px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul>
<li class="two_line" reference_id="R33">
<a href="/pubmed/15205351/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.</a><span class="one_line_source">[Cancer Res.  2004]</span><div class="alt-note">
<div class="authors">Dolan ME, Newbold KG, Nagasubramanian R, Wu X, Ratain MJ, Cook EH Jr, Badner JA</div>
<div class="citation">Cancer Res. 2004 Jun 15; 64(12):4353-6.</div>
</div>
</li>
<li class="two_line" reference_id="R34">
<a href="/pubmed/18300947/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.</a><span class="one_line_source">[Pharmacogenet Genomics.  2008]</span><div class="alt-note">
<div class="authors">Shukla SJ, Duan S, Badner JA, Wu X, Dolan ME</div>
<div class="citation">Pharmacogenet Genomics. 2008 Mar; 18(3):253-62.</div>
</div>
</li>
<li class="two_line" reference_id="R24">
<a href="/pubmed/17701890/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.</a><span class="one_line_source">[Am J Hum Genet.  2007]</span><div class="alt-note">
<div class="authors">Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX, Schweitzer AC, Blume JE, Dolan ME</div>
<div class="citation">Am J Hum Genet. 2007 Sep; 81(3):427-37.</div>
</div>
</li>
<li class="two_line" reference_id="R36">
<a href="/pubmed/19164090/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Whole-genome approach implicates CD44 in cellular resistance to carboplatin.</a><span class="one_line_source">[Hum Genomics.  2009]</span><div class="alt-note">
<div class="authors">Shukla SJ, Duan S, Wu X, Badner JA, Kasza K, Dolan ME</div>
<div class="citation">Hum Genomics. 2009 Jan; 3(2):128-42.</div>
</div>
</li>
<li class="two_line" reference_id="R37">
<a href="/pubmed/19043577/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines.</a><span class="one_line_source">[PLoS Genet.  2008]</span><div class="alt-note">
<div class="authors">Choy E, Yelensky R, Bonakdar S, Plenge RM, Saxena R, De Jager PL, Shaw SY, Wolfish CS, Slavik JM, Cotsapas C, Rivas M, Dermitzakis ET, Cahir-McFarland E, Kieff E, Hafler D, Daly MJ, Altshuler D</div>
<div class="citation">PLoS Genet. 2008 Nov; 4(11):e1000287.</div>
</div>
</li>
<li class="two_line" reference_id="R38">
<a href="/pubmed/15269782/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic analysis of genome-wide variation in human gene expression.</a><span class="one_line_source">[Nature.  2004]</span><div class="alt-note">
<div class="authors">Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, Cheung VG</div>
<div class="citation">Nature. 2004 Aug 12; 430(7001):743-7.</div>
</div>
</li>
<li class="two_line" reference_id="R39">
<a href="/pubmed/18344981/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetics of gene expression and its effect on disease.</a><span class="one_line_source">[Nature.  2008]</span><div class="alt-note">
<div class="authors">Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, Carlson S, Helgason A, Walters GB, Gunnarsdottir S, Mouy M, Steinthorsdottir V, Eiriksdottir GH, Bjornsdottir G, Reynisdottir I, Gudbjartsson D, Helgadottir A, Jonasdottir A, Jonasdottir A, Styrkarsdottir U, Gretarsdottir S, Magnusson KP, Stefansson H, Fossdal R, Kristjansson K, Gislason HG, Stefansson T, Leifsson BG, Thorsteinsdottir U, Lamb JR, Gulcher JR, Reitman ML, Kong A, Schadt EE, Stefansson K</div>
<div class="citation">Nature. 2008 Mar 27; 452(7186):423-8.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P27" name="crb--P27" rid="P27" style="position: absolute; visibility: visible; width: 370px; top: 12565px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul>
<li class="two_line" reference_id="R40">
<a href="/pubmed/9488481/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ZIP kinase, a novel serine/threonine kinase which mediates apoptosis.</a><span class="one_line_source">[Mol Cell Biol.  1998]</span><div class="alt-note">
<div class="authors">Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S</div>
<div class="citation">Mol Cell Biol. 1998 Mar; 18(3):1642-51.</div>
</div>
</li>
<li class="two_line" reference_id="R41">
<a href="/pubmed/17953487/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ZIPK: a unique case of murine-specific divergence of a conserved vertebrate gene.</a><span class="one_line_source">[PLoS Genet.  2007]</span><div class="alt-note">
<div class="authors">Shoval Y, Pietrokovski S, Kimchi A</div>
<div class="citation">PLoS Genet. 2007 Oct; 3(10):1884-93.</div>
</div>
</li>
<li class="two_line" reference_id="R42">
<a href="/pubmed/11237533/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> DAP kinase-a proapoptotic gene that functions as a tumor suppressor.</a><span class="one_line_source">[Exp Cell Res.  2001]</span><div class="alt-note">
<div class="authors">Raveh T, Kimchi A</div>
<div class="citation">Exp Cell Res. 2001 Mar 10; 264(1):185-92.</div>
</div>
</li>
<li class="two_line" reference_id="R44">
<a href="/pubmed/15219621/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death.</a><span class="one_line_source">[Semin Cancer Biol.  2004]</span><div class="alt-note">
<div class="authors">Bialik S, Kimchi A</div>
<div class="citation">Semin Cancer Biol. 2004 Aug; 14(4):283-94.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P28" name="crb--P28" rid="P28" style="position: absolute; visibility: visible; width: 370px; top: 12774px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul>
<li class="two_line" reference_id="R45">
<a href="/pubmed/12692539/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.</a><span class="one_line_source">[Nat Med.  2003]</span><div class="alt-note">
<div class="authors">Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD</div>
<div class="citation">Nat Med. 2003 May; 9(5):568-74.</div>
</div>
</li>
<li class="two_line" reference_id="R46">
<a href="/pubmed/16361617/" ref="reftype=pubmed&amp;article-id=3167019&amp;issue-id=199786&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.</a><span class="one_line_source">[J Clin Oncol.  2005]</span><div class="alt-note">
<div class="authors">Ramirez JL, Rosell R, Taron M, Sanchez-Ronco M, Alberola V, de Las Peñas R, Sanchez JM, Moran T, Camps C, Massuti B, Sanchez JJ, Salazar F, Catot S, Spanish Lung Cancer Group.</div>
<div class="citation">J Clin Oncol. 2005 Dec 20; 23(36):9105-12.</div>
</div>
</li>
</ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T07:26:28-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal103&amp;ncbi_phid=CE8AEA9ADD52C03100000000030301F7&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3167019%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3167019/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>